Mixed connective tissue disease

M13_MCTD

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M35.9 Hospital discharge: ICD-9 — 7109 Hospital discharge: ICD-8 — 73499 Cause of death: ICD-10 — M35.9 Cause of death: ICD-9 — 7109 Cause of death: ICD-8 — 73499 2 out of 7 registries used, show all original rules.	2039
4. Check minimum number of events None	2039
5. Include endpoints M13_OVERLAP	2545
6. Filter based on genotype QC (FinnGen only)	2462

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF7

NAME	M13_MCTD
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	M13_OVERLAP
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M359
HD_ICD_9	7109
HD_ICD_8	73499
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M359
COD_ICD_9	7109
COD_ICD_8	73499
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Mixed connective tissue disease based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Other overlap syndromes

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	14204	11040	3044
Only index persons	12490	9991	2499
Unadjusted period prevalence (%)
Whole population	0.27	0.32	0.09
Only index persons	0.31	0.37	0.10
Median age at first event (years)
Whole population	54.56	53.37	58.70
Only index persons	52.81	51.86	56.64

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2462	1970	492
Unadjusted period prevalence (%)	0.60	0.70	0.23
Median age at first event (years)	51.74	50.05	58.50

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2545: Matched controls
25450

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

XX9XE

NOMESCO Finland

Other ultrasound examination

30.1

318.9

213

L04AX03

ATC

methotrexate; systemic

8.8

307.7

890

1472

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

15806.8

307.7

1956

XPX04

NOMESCO Finland

Angioscopy

76.0

307.7

177

L04AX01

ATC

azathioprine; systemic

13.4

307.7

521

478

M35.1

ICD-10 Finland

Other overlap syndromes

+∞

307.7

678

I73.0

ICD-10 Finland

Raynaud syndrome

20.3

307.7

295

163

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

60.4

307.7

341

P01BA02

ATC

hydroxychloroquine; oral

34.2

307.7

1621

1242

C08CA05

ATC

nifedipine; systemic

8.4

307.7

487

694

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

10.9

307.7

761

962

H02AB06

ATC

prednisolone; systemic

5.5

307.7

1932

9252

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

17.6

307.7

1410

1682

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

35.6

307.7

580

209

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

6.5

276.1

513

945

L04AA06

ATC

mycophenolic acid; systemic

16.4

256.5

222

147

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.9

253.5

1453

6422

L88

ICPC

Rheumatoid/seropositive arthritis

7.5

220.4

340

511

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

56.6

219.6

124

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

10.4

204.2

236

248

M34.1

ICD-10 Finland

CR(E)ST syndrome

32.3

203.5

132

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

4.7

191.6

515

1295

L01BA01

ATC

methotrexate; systemic

6.9

178.2

293

469

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

6.4

171.7

307

535

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.1

165.5

1506

8144

H02AB07

ATC

prednisone; oral

3.6

158.9

646

2170

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

49.6

156.9

SBA10

NOMESCO Finland

Measurement of salivary flow rate

15.1

151.9

136

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

4.7

149.7

390

947

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

57.9

149.3

M35.3

ICD-10 Finland

Polymyalgia rheumatica

6.3

147.0

261

450

M05BA04

ATC

alendronic acid; oral

4.1

139.2

445

1259

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

69.3

135.6

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

57.0

127.6

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

14.7

125.9

114

M79.0

ICD-10 Finland

Rheumatism, unspecified

5.6

121.4

247

483

PAW37

NOMESCO Finland

Biopsy of temporal artery

18.2

108.9

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.6

107.5

991

5084

M13.9

ICD-10 Finland

Arthritis, unspecified

3.9

106.0

355

1028

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

4.3

105.2

295

751

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.6

103.7

397

1257

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

53.9

101.6

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

9.0

101.4

127

147

QC6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in hand

43.9

100.6

R50.9

ICD-10 Finland

Fever, unspecified

2.9

97.0

547

2176

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

7.1

92.9

144

214

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.3

90.4

1375

8613

7109X

ICD-9 Finland

Diffuse diseases of connective tissue, Unspecified diffuse connective tissue disease

+∞

89.1

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.2

85.0

377

1300

L93.0

ICD-10 Finland

Discoid lupus erythematosus

16.4

84.9

H04.10

ICD-10 Finland

Dry eye syndrome

2.9

84.3

474

1871

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

5.7

78.1

151

280

M25.5

ICD-10 Finland

Pain in joint

2.2

77.5

1058

6227

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.8

74.1

244

693

ZX120

NOMESCO Finland

Intravenous

3.0

73.8

362

1319

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

4.7

73.3

176

394

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

4.3

72.9

201

502

M32

ICD-10 Finland

Systemic lupus erythematosus

40.7

72.3

R4120

NOMESCO Finland

Occupational therapy

3.4

71.4

277

876

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

10.2

71.3

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

5.7

70.5

135

248

TEA00

NOMESCO Finland

Biopsy of lip

9.2

69.6

A02BC02

ATC

pantoprazole; systemic

2.2

67.6

1899

14426

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.0

66.1

328

1199

M33.2

ICD-10 Finland

Polymyositis

26.9

65.5

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.3

65.1

663

3423

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

64.7

441

1902

L04AA13

ATC

[U] leflunomide

5.0

64.1

142

297

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

7.4

63.7

132

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

27.3

62.9

M05BA07

ATC

risedronic acid; oral

4.6

62.4

154

352

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

6.0

61.8

112

195

L04AD01

ATC

ciclosporin; systemic

6.1

61.7

109

185

R06.0

ICD-10 Finland

Dyspnoea

2.1

61.3

809

4610

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

5.6

59.0

114

211

M35.5

ICD-10 Finland

Multifocal fibrosclerosis

26.0

58.9

M79.7

ICD-10 Finland

Fibromyalgia

3.8

58.7

185

508

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

58.6

669

3597

TGC00

NOMESCO Finland

Bronchial lavation

5.4

58.2

118

228

NH3EA

NOMESCO Finland

Feet X-ray examination with load

5.5

58.1

116

221

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.7

58.0

343

1373

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

57.4

702

3870

E0000UV, ,

ATC

1.9

56.4

1199

8023

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

17.6

55.0

ELA30

NOMESCO Finland

Biopsy of salivary gland

20.3

54.8

A07EC01

ATC

sulfasalazine; oral, rectal

2.8

54.6

301

1160

UJF32

NOMESCO Finland

Coloscopy

2.0

53.9

753

4345

XG410

NOMESCO Finland

Flow-volume spirometry

4.0

53.9

159

416

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

5.1

53.8

115

233

GD1AD

NOMESCO Finland

Thorax CT examination

3.4

53.6

206

645

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.0

52.2

242

848

NXL00

NOMESCO Finland

Biopsy of muscle

15.1

52.0

N02AX02

ATC

tramadol; systemic, rectal

1.9

51.6

1171

7931

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.1

51.6

621

3384

N03AX16

ATC

[U] pregabalin

2.0

51.3

706

4041

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

4.8

51.2

119

259

G04BE03

ATC

sildenafil; oral

8.6

51.1

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.2

50.7

495

2484

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

50.3

624

3436

C08CA02

ATC

felodipine; oral

2.7

50.2

290

1144

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.5

48.4

344

1501

L04AA01

ATC

[U] ciclosporin

6.4

48.1

131

S01XA18

ATC

ciclosporin; ophthalmic

8.9

48.0

A02BC03

ATC

lansoprazole; oral

1.9

47.8

831

5133

H02AB04

ATC

methylprednisolone; systemic

2.2

47.6

468

2349

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.2

47.3

198

652

C03CA01

ATC

furosemide; systemic

1.9

46.6

741

4435

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

5.3

46.6

188

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

6.1

45.5

135

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

4.0

44.6

132

346

D68.8

ICD-10 Finland

Other specified coagulation defects

6.7

44.3

109

J01MA12

ATC

levofloxacin; systemic

2.1

43.8

510

2726

M34.0

ICD-10 Finland

Progressive systemic sclerosis

57.8

43.5

A07AA02

ATC

nystatin; oral

2.9

42.6

207

743

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

14.8

42.5

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

41.7

412

2063

J01FF01

ATC

clindamycin; systemic

1.9

41.4

756

4704

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.8

40.9

217

816

M01AH01

ATC

celecoxib; oral

2.0

40.5

539

3016

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.4

40.3

304

1358

M81.9

ICD-10 Finland

Osteoporosis, unspecified

3.1

39.9

172

576

WZA10

NOMESCO Finland

Extensive medical or dental certificate

5.9

39.5

126

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.5

39.4

277

1197

M35.7

ICD-10 Finland

Hypermobility syndrome

5.1

39.3

170

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.6

38.9

240

974

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

38.9

404

2060

M05BX04

ATC

denosumab; parenteral

2.8

38.6

213

817

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.2

38.1

155

501

L99

ICPC

Musculoskeletal disease other

4.3

38.0

236

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

192.8

36.9

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.0

36.8

166

570

M35

ICD-10 Finland

Other systemic involvement of connective tissue

128.5

35.8

318

Kela drug reimbursment

Teriparatide

9.9

35.7

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

35.6

295

1369

A02BC01

ATC

omeprazole; systemic

1.8

35.6

747

4809

A02BC05

ATC

esomeprazole; systemic

1.7

35.5

1102

7907

P01BA01

ATC

chloroquine; systemic

9.5

35.4

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

9.5

34.5

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.4

34.0

241

1044

C08CA01

ATC

amlodipine; oral

1.7

33.6

922

6376

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.7

33.5

813

5438

N06AX21

ATC

duloxetine; oral

2.1

32.7

375

1977

EL3AE

NOMESCO Finland

Salivary gland ultrasound examination

8.5

32.6

N03AX12

ATC

[U] gabapentin; oral

1.9

32.5

474

2716

J01MA14

ATC

moxifloxacin; systemic

2.3

32.4

259

1182

J01DB01

ATC

cefalexin; oral

1.9

32.4

2120

18387

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.6

32.3

107

303

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

32.3

1082

7863

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

48.2

31.6

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

3.4

31.6

118

362

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

3.8

31.5

266

TNG10

NOMESCO Finland

Puncture of knee

5.7

31.5

106

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

31.3

312

1559

ZX140

NOMESCO Finland

Intra articular

6.0

31.2

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

5.1

31.1

133

M60.9

ICD-10 Finland

Myositis, unspecified

8.8

31.1

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

30.7

272

1295

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

5.5

30.7

112

M01AC06

ATC

meloxicam; systemic, rectal

1.6

30.4

984

7058

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

5.6

30.2

103

M81.4

ICD-10 Finland

Drug-induced osteoporosis

10.4

29.8

H05AA02

ATC

teriparatide; parenteral

9.1

29.5

J01MA02

ATC

ciprofloxacin; systemic

1.6

29.4

948

6777

R68.2

ICD-10 Finland

Dry mouth, unspecified

8.0

29.4

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

29.3

492

2938

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.6

29.3

275

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.8

29.0

151

561

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.3

28.9

223

1001

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

28.8

273

1336

M01AH02

ATC

rofecoxib; oral

2.0

28.7

352

1896

H26.3

ICD-10 Finland

Drug-induced cataract

7.7

28.5

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

11.2

28.5

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

27.8

316

1654

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

27.7

230

1066

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

27.6

1019

7498

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

27.6

345

1869

H02AB09

ATC

hydrocortisone; systemic

3.7

27.6

248

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

27.4

935

6747

J02AC01

ATC

fluconazole; systemic

1.6

27.3

1165

8860

M05BB03

ATC

alendronic acid and colecalciferol; oral

3.7

27.3

245

A01AB09

ATC

miconazole; local oral

2.2

27.3

259

1267

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

27.3

973

7096

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

3.2

26.7

107

343

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

26.4

469

2841

D07AC01

ATC

betamethasone; topical

1.6

26.3

918

6645

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

26.3

705

4783

M13.0

ICD-10 Finland

Polyarthritis, unspecified

5.0

26.3

117

G73.7*M35.0

ICD-10 Finland

Myopathy in sicca syndrome [Sjögren]

52.3

26.2

L20

ICPC

Joint symptom/complaint NOS

2.9

26.2

129

465

Z3231

NOMESCO Finland

Registered nurse

1.7

26.2

686

4625

R51.80

ICD-10 Finland

Headache

1.8

26.2

454

2731

A02BA02

ATC

ranitidine; systemic

1.8

25.8

502

3120

L01AA01

ATC

cyclophosphamide; systemic

10.1

25.6

N06AA09

ATC

amitriptyline; systemic

2.0

25.5

284

1474

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.0

25.5

113

384

K11.2

ICD-10 Finland

Sialoadenitis

3.0

25.5

112

379

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.4

25.4

183

797

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

5.7

25.2

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

4.2

24.9

164

XW000

NOMESCO Finland

Bone marrow biopsy

2.9

24.7

120

430

M79.6

ICD-10 Finland

Pain in limb

1.5

24.6

1101

8399

M33.1

ICD-10 Finland

Other dermatomyositis

43.3

24.6

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

4.6

24.5

128

S18

ICPC

Laceration/cut

1.5

24.3

1103

8432

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.3

23.6

270

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.0

23.6

283

1508

K74.3

ICD-10 Finland

Primary biliary cirrhosis

6.4

23.6

C07AB07

ATC

bisoprolol; oral

1.5

23.4

1116

8600

5BA08, ,

NOMESCO Finland

7.9

23.4

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

47.1

23.3

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

8.9

23.3

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.1

23.2

319

J01AA02

ATC

doxycycline; systemic

1.6

23.0

1981

17347

R06AE07

ATC

cetirizine; oral

1.5

23.0

1166

9094

73499

ICD-8 Finland

Diffuse diseases of connective tissue, Other and unspecified

+∞

22.9

K90.0

ICD-10 Finland

Coeliac disease

3.0

22.9

103

353

R1250

NOMESCO Finland

Evaluation of functional capability

3.5

22.9

240

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

4.3

22.6

141

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.0

22.2

102

354

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

5.1

22.1

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

22.1

192

905

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

7.6

22.1

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

22.0

369

2189

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

22.0

496

3198

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.7

21.8

120

459

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

21.7

501

3248

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

39.0

21.7

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

21.5

1102

8575

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.2

21.5

195

935

E000001, ,

ATC

1.7

21.5

515

3372

TAB00

NOMESCO Finland

Lumbar puncture

2.5

21.4

136

559

R03AC02

ATC

salbutamol; inhalant

1.5

21.4

1417

11615

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

21.3

462

2944

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

26.6

21.3

J01DA01

ATC

[U] cefalexin

1.5

21.2

1560

13050

M01CB03

ATC

auranofin; oral

5.7

21.2

N02BE01

ATC

paracetamol; systemic, rectal

1.8

21.1

2251

20526

NH3AE

NOMESCO Finland

Feet ultrasound examination

8.5

21.0

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

8.5

21.0

K11.70

ICD-10 Finland

Hypoptyalism

6.5

20.9

N02BF01

ATC

gabapentin; oral

2.0

20.9

238

1243

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

7.7

20.8

R53

ICD-10 Finland

Malaise and fatigue

1.6

20.8

611

4202

1XC02, ,

NOMESCO Finland

6.2

20.7

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

20.6

270

1481

N35.9

ICD-10 Finland

Urethral stricture, unspecified

6.5

20.5

I77.6

ICD-10 Finland

Arteritis, unspecified

18.4

20.4

A02BX02

ATC

sucralfate; oral

2.6

20.3

118

464

L95

ICPC

Osteoporosis

2.6

20.3

122

488

L28

ICPC

Limited function/disability (L)

1.7

20.1

422

2663

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

3.4

20.0

211

L17

ICPC

Foot/toe symptom/complaint

1.5

20.0

721

5188

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.4

19.9

139

597

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.3

19.9

232

J05AB11

ATC

valaciclovir; oral

1.7

19.8

389

2410

B01AB05

ATC

enoxaparin; parenteral

1.5

19.7

770

5636

M79.1

ICD-10 Finland

Myalgia

1.7

19.7

403

2525

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.2

19.6

167

780

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

7.4

19.5

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

6.0

19.5

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

19.5

664

4714

Z2221

NOMESCO Finland

Medical doctor

1.5

19.5

696

4994

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

6.3

19.3

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.2

19.3

175

839

A01AB04

ATC

amphotericin B; local oral

2.4

19.2

137

593

J01FA06

ATC

roxithromycin; oral

1.5

19.2

1018

7919

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.3

19.1

152

691

R4110

NOMESCO Finland

Physiotherapy

1.5

19.1

675

4830

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

19.0

407

2579

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

19.0

187

926

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.7

19.0

170

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.0

19.0

227

1206

L50.9

ICD-10 Finland

Urticaria, unspecified

2.5

18.6

114

460

A01

ICPC

Pain general/multiple sites

1.9

18.6

250

1380

R52.9

ICD-10 Finland

Pain, unspecified

1.9

18.6

256

1425

XQ860

NOMESCO Finland

Laser Doppler measurement/scan of capillary perfusion

191.4

18.6

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

18.4

342

2083

Z3226

NOMESCO Finland

Physiotherapist

1.6

18.3

454

2987

L94.0

ICD-10 Finland

Localized scleroderma [morphea]

7.5

18.2

NF1AA

NOMESCO Finland

Hip X-ray examination

2.0

18.2

215

1137

M01AH05

ATC

etoricoxib; oral

1.5

18.2

1545

13099

M05BA06

ATC

ibandronic acid; systemic

3.1

18.0

252

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.0

17.9

219

1171

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.5

17.9

116

481

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

4.4

17.8

101

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

6.0

17.8

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

17.8

208

1096

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

5.2

17.7

C02KX04

ATC

macitentan; oral

37.0

17.6

J05AB01

ATC

aciclovir; systemic

1.5

17.6

581

4083

7108X

ICD-9 Finland

Diffuse diseases of connective tissue, Other specified diffuse diseases of connective tissue

95.7

17.6

B02.9

ICD-10 Finland

Zoster without complication

2.1

17.5

176

877

K07.60

ICD-10 Finland

Snapping jaw

2.1

17.5

166

809

A05AA02

ATC

ursodeoxycholic acid; oral

3.4

17.4

180

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.1

17.4

181

915

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

17.3

361

2268

R13

ICD-10 Finland

Dysphagia

2.0

17.2

180

912

M54.5

ICD-10 Finland

Low back pain

1.5

17.1

905

6995

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

17.1

309

1866

S97

ICPC

Chronic ulcer skin

2.2

17.0

141

652

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

5.6

17.0

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

16.9

263

1519

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

16.9

270

1573

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

16.9

191

995

R00.2

ICD-10 Finland

Palpitations

1.9

16.8

220

1203

M01AX01

ATC

nabumetone; oral

2.4

16.8

119

514

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.4

16.7

113

478

J99.1*M34.8

ICD-10 Finland

Respiratory disorders in systemic: sclerosis

+∞

16.7

XF402

NOMESCO Finland

ECG with work load test

1.8

16.4

241

1369

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

16.3

201

1078

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

16.3

367

2351

L04AB01

ATC

etanercept; parenteral

3.4

16.2

169

XF404

NOMESCO Finland

Ambulatory ECG

1.9

16.2

205

1110

M25.9

ICD-10 Finland

Joint disorder, unspecified

4.1

16.1

105

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

16.1

286

1719

J01FA10

ATC

azithromycin; systemic

1.4

16.0

1457

12365

AN1

Coronary angiography

1.9

16.0

216

1193

R76.0

ICD-10 Finland

Raised antibody titre

11.7

16.0

G73.7

ICD-10 Finland

Myopathy in other diseases classified elsewhere

47.8

16.0

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

16.0

482

3310

I27.0

ICD-10 Finland

Primary pulmonary hypertension

18.6

16.0

R60.0

ICD-10 Finland

Localized oedema

1.7

15.9

287

1731

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.2

15.9

201

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

15.9

356

2277

7102A

ICD-9 Finland

Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM PRIMARIUM]

60.4

15.8

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.6

15.8

381

M01CB01

ATC

sodium aurothiomalate; parenteral

3.6

15.7

143

M31.1

ICD-10 Finland

Thrombotic microangiopathy

33.6

15.7

B01AA03

ATC

warfarin; systemic

1.6

15.7

359

2307

R52.2

ICD-10 Finland

Other chronic pain

2.4

15.7

112

486

Z2446

NOMESCO Finland

Social worker

2.0

15.6

168

859

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

15.5

208

1147

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

4.0

15.5

108

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

161.0

15.5

J99.1*M35.0

ICD-10 Finland

Respiratory disorders in sicca syndrome [Sjögren]

161.0

15.5

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

15.5

215

1199

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

15.5

231

1318

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.5

15.4

101

421

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

15.3

370

2409

J01CA04

ATC

amoxicillin; systemic

1.5

15.3

2022

18300

M01AB55

ATC

diclofenac, combinations; oral

2.0

15.1

175

918

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.8

15.1

119

B07.9

ICD-10 Finland

Verruca simplex

2.5

15.1

389

73491

ICD-8 Finland

Diffuse diseases of connective tissue, Collagenosis NUD

45.3

15.1

A02BA04

ATC

nizatidine; systemic

1.9

15.0

184

985

WW200

NOMESCO Finland

Immunization

2.9

15.0

257

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

15.0

290

1783

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

15.0

270

1628

D07AB08

ATC

desonide; topical

1.7

14.9

267

1606

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

3.7

14.9

125

G72.9

ICD-10 Finland

Myopathy, unspecified

4.9

14.7

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

2.0

14.7

176

934

286

Kela drug reimbursment

Ciclosporin eye drop

21.2

14.6

N02AC04

ATC

dextropropoxyphene; oral

2.5

14.6

377

J01EA01

ATC

trimethoprim; systemic

1.5

14.6

697

5253

ZXA00

NOMESCO Finland

Right side

1.5

14.6

604

4429

R07.3

ICD-10 Finland

Other chest pain

1.8

14.5

252

1503

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

14.5

427

2913

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.7

14.3

119

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

14.3

198

1102

A46

ICD-10 Finland

Erysipelas

1.7

14.3

298

1867

SPAT1301

SPAT

No procedures

1.4

14.3

711

5393

R05

ICD-10 Finland

Cough

1.5

14.2

519

3708

RS221, ,

NOMESCO Finland

3.6

14.2

134

SPAT1229

SPAT

Assessment of need for aid

1.9

14.2

180

975

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

2.9

14.2

221

N06AX11

ATC

mirtazapine; oral

1.4

14.1

820

6395

C02KX01

ATC

bosentan; oral

42.7

14.1

N02AA05

ATC

oxycodone; systemic

1.6

14.1

380

2539

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.5

14.0

372

M01AE02

ATC

naproxen; oral, rectal

1.4

13.9

1396

11916

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

13.9

443

3074

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

13.9

103

455

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.2

13.9

176

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

3.5

13.9

141

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

13.8

268

1648

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.1

13.8

124

593

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

13.7

323

2087

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

13.7

1255

10543

WX892

NOMESCO Finland

Monitored bed care

1.9

13.7

167

893

M02AA07

ATC

piroxicam; topical

1.4

13.6

845

6659

A12BA01

ATC

potassium chloride; oral

2.3

13.5

100

441

N06AB04

ATC

citalopram; systemic

1.5

13.5

514

3698

ELB10

NOMESCO Finland

Excision of minor salivary gland

11.0

13.5

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

13.5

263

1619

D07AD01

ATC

clobetasol; topical

1.5

13.5

404

2763

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.5

13.5

355

C03DA01

ATC

spironolactone; oral

1.7

13.4

257

1575

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

6.1

13.4

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.0

13.4

201

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.0

13.4

150

779

RT274, ,

NOMESCO Finland

18.3

13.4

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

4.9

13.3

SBA00

NOMESCO Finland

Microbiological examinations

2.7

13.3

274

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.9

13.3

172

938

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

13.3

829

6533

P01AB01

ATC

metronidazole; oral, rectal

1.4

13.2

1013

8258

M01AX17

ATC

nimesulide; oral

1.5

13.2

565

4160

AA1AD

NOMESCO Finland

CT of head and brain

1.5

13.2

581

4301

N02BF02

ATC

pregabalin; oral

2.0

13.1

155

819

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.0

13.1

198

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

13.1

259

1600

Z01.2

ICD-10 Finland

Dental examination

1.4

13.0

1089

8992

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

13.0

460

3258

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

13.0

263

1635

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

13.0

120

580

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.5

13.0

337

N03AE01

ATC

clonazepam; systemic

2.0

13.0

143

738

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

12.9

295

1891

R03AC03

ATC

terbutaline; inhalant

1.6

12.9

345

2297

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

12.9

168

917

XA402

NOMESCO Finland

ENMG

2.7

12.9

267

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

12.9

523

3808

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

4.5

12.8

Z01.9

ICD-10 Finland

Special examination, unspecified

2.0

12.8

150

790

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

12.8

213

1255

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

12.8

628

4740

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

12.7

410

2848

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

12.6

987

8051

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

12.6

374

2549

K76.9

ICD-10 Finland

Liver disease, unspecified

3.4

12.6

135

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

12.6

699

5388

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

12.6

150

796

SAA04

NOMESCO Finland

Special examination of mouth

2.0

12.6

131

663

N05CF01

ATC

zopiclone; oral

1.4

12.5

745

5809

G44.2

ICD-10 Finland

Tension-type headache

1.6

12.5

360

2438

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

12.5

204

1195

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

12.5

1740

15522

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

10.1

12.5

J45.8

ICD-10 Finland

Mixed asthma

2.4

12.5

362

G05.8*M32.1

ICD-10 Finland

Encephalitis in systemic lupus erythematosus

130.6

12.4

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

12.4

305

1990

WX002

NOMESCO Finland

Sedation and analgesia

1.5

12.4

442

3132

S01KA02

ATC

hypromellose; ophthalmic

2.9

12.4

199

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

12.4

127

639

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.0

12.4

128

646

E000006, ,

ATC

1.8

12.3

174

975

D02AX

ATC

Other emollients and protectives

2.4

12.3

358

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.1

12.3

114

552

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.8

12.3

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

3.9

12.3

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.5

12.2

328

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

12.2

441

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

12.2

848

6778

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

9.0

12.2

M34

ICD-10 Finland

Systemic sclerosis

37.7

12.2

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

4.0

12.2

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

12.2

1190

10031

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.5

12.2

323

RT271, ,

NOMESCO Finland

15.9

12.1

M06

ICD-10 Finland

Other rheumatoid arthritis

4.6

12.1

R01AD09

ATC

mometasone; nasal

1.4

12.1

1125

9408

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

12.1

217

1305

L04AB04

ATC

adalimumab; parenteral

2.7

12.1

247

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.9

12.0

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

12.0

627

4776

M31.3

ICD-10 Finland

Wegener granulomatosis

10.1

12.0

M45

ICD-10 Finland

Ankylosing spondylitis

2.8

12.0

203

A07EA06

ATC

budesonide; oral, local oral

2.3

11.9

420

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.8

11.9

209

D02AE01

ATC

carbamide; topical

1.9

11.9

158

868

L94.9

ICD-10 Finland

Localized connective tissue disorder, unspecified

46.9

11.9

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.8

11.9

204

EBA10

NOMESCO Finland

Operative extraction of tooth

1.6

11.8

275

1771

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.6

11.8

256

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

9.0

11.7

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

11.7

338

2288

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.6

11.7

251

A03

ICPC

Fever

1.5

11.7

388

2707

A41.9

ICD-10 Finland

Sepsis, unspecified

2.4

11.7

323

H03AA01

ATC

levothyroxine sodium; systemic

1.4

11.7

614

4679

I73.8

ICD-10 Finland

Other specified peripheral vascular diseases

16.5

11.7

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

11.6

767

6070

NHQ40

NOMESCO Finland

Amputation of toe

3.6

11.6

103

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

11.6

352

2410

SPAT1255

SPAT

Intravenous administration of medicine

1.9

11.5

154

848

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

11.5

534

3976

M05BA01

ATC

etidronic acid; systemic

5.3

11.5

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.2

11.5

143

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.4

11.5

313

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

10.1

11.5

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

11.5

262

1679

JN4BD

NOMESCO Finland

Extensive body CT

1.7

11.5

219

1340

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.3

11.5

357

L87.1

ICD-10 Finland

Reactive perforating collagenosis

+∞

11.5

XQ844

NOMESCO Finland

Other microscope or electron microscope examination

+∞

11.5

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

11.5

881

7140

NJ3DG

NOMESCO Finland

Very extensive MRI examination of extremities with high intensity magnet

120.5

11.4

-1, ,

NOMESCO Finland

1.4

11.4

761

6031

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

11.4

196

1166

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

5.4

11.3

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.8

11.3

163

919

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.7

11.3

191

1129

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

3.6

11.3

105

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.1

11.3

107

523

RT272, ,

NOMESCO Finland

8.3

11.3

D07AC13

ATC

mometasone; topical

1.4

11.3

667

5181

UKC02

NOMESCO Finland

Cystoscopy

1.6

11.3

289

1904

NDL52

NOMESCO Finland

Tenosynovectomy of hand

4.2

11.3

R76.8

ICD-10 Finland

Other specified abnormal immunological findings in serum

35.2

11.3

XG460

NOMESCO Finland

Short time oxymetry

3.3

11.2

130

D01AE16

ATC

amorolfine; topical

1.6

11.2

263

1698

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

11.2

141

763

M35.2

ICD-10 Finland

Behçet disease

25.1

11.1

SPAT1263

SPAT

Sampling

1.3

11.0

960

7915

R42

ICD-10 Finland

Dizziness and giddiness

1.4

11.0

516

3847

R11

ICD-10 Finland

Nausea and vomiting

1.7

11.0

211

1294

ZXE00

NOMESCO Finland

One hour or less

1.3

10.9

905

7404

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

3.8

10.9

J01MA06

ATC

norfloxacin; oral

1.5

10.9

330

2257

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

10.9

518

3873

Z50.1

ICD-10 Finland

Other physical therapy

1.9

10.9

130

691

XQ848

NOMESCO Finland

Dermatological photography

2.4

10.9

291

E000002, ,

ATC

1.6

10.9

253

1629

UJF92

NOMESCO Finland

Capsular endoscopy

2.7

10.9

220

ZXA05

NOMESCO Finland

Left side

1.4

10.9

538

4051

S29

ICPC

Skin symptom/complaint other

1.5

10.8

438

3177

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.3

10.8

373

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.3

10.8

354

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

10.8

573

4366

XCK00

NOMESCO Finland

Perimetry

1.9

10.8

141

772

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

10.8

127

672

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.8

10.7

199

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.3

10.7

124

C02DE02, ,

ATC

4.1

10.7

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

10.6

132

710

L93.1

ICD-10 Finland

Subacute cutaneous lupus erythematosus

60.3

10.6

SBB10

NOMESCO Finland

Dental impressions

1.8

10.6

154

871

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.0

10.6

118

612

J01DA09

ATC

[U] cefadroxil

1.4

10.6

615

4755

ND1AE

NOMESCO Finland

Wrist ultrasound examination

8.0

10.6

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

3.9

10.6

M03BX02

ATC

tizanidine; oral

1.3

10.6

1512

13356

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.0

10.6

111

564

M48.0

ICD-10 Finland

Spinal stenosis

1.6

10.5

264

1729

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

3.3

10.5

120

L84

ICD-10 Finland

Corns and callosities

2.2

10.5

403

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

10.5

205

1262

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.6

10.4

242

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

10.4

162

935

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.5

10.4

260

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

10.4

431

3137

R01AD08

ATC

fluticasone; nasal

1.4

10.4

681

5365

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

10.4

129

695

C08DB01

ATC

diltiazem; oral

2.0

10.3

108

548

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

10.3

199

1221

ZXD05

NOMESCO Finland

Urgent procedure

1.4

10.3

680

5365

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

9.6

10.2

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

10.2

649

5087

ZY010

NOMESCO Finland

Hospital outpatient

1.9

10.2

122

649

ZX100

NOMESCO Finland

Oral

3.3

10.1

118

R4190

NOMESCO Finland

Nutritional therapy

2.2

10.1

397

ZXA10

NOMESCO Finland

Bilateral

1.5

10.1

411

2983

N30.0

ICD-10 Finland

Acute cystitis

1.5

10.1

407

2949

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

3.0

10.0

145

XX1VW

NOMESCO Finland

Written report from radiologist

4.1

10.0

SPAT1254

SPAT

Administration of medicine

1.5

9.9

312

2149

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

9.9

530

4035

A03FA02

ATC

cisapride; oral, rectal

1.7

9.9

173

1034

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.5

9.9

237

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

2.0

9.9

100

502

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

9.8

1698

15318

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

9.8

403

2927

J47

ICD-10 Finland

Bronchiectasis

2.8

9.8

174

R03BA08

ATC

ciclesonide; inhalant

1.6

9.8

218

1388

M13.8

ICD-10 Finland

Other specified arthritis

3.5

9.8

Z71.8

ICD-10 Finland

Other specified counselling

1.3

9.7

719

5762

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

3.7

9.7

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

9.7

667

5288

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

9.6

357

2542

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

9.6

121

654

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

4.2

9.6

SXC03

NOMESCO Finland

Other oral or dental procedure

3.4

9.6

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

2.4

9.6

271

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

9.6

218

1396

L71.8

ICD-10 Finland

Other rosacea

2.8

9.6

171

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.5

9.5

223

L30.8

ICD-10 Finland

Other specified dermatitis

2.3

9.5

309

PD4AD

NOMESCO Finland

CT of lower extremity arteries

4.8

9.5

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

2.7

9.5

194

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.1

9.5

447

K75.4

ICD-10 Finland

Autoimmune hepatitis

9.1

9.5

N03AF02

ATC

oxcarbazepine; oral

2.2

9.5

368

N05CD07

ATC

temazepam; oral

1.6

9.4

243

1603

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

9.4

168

1010

JN4AD

NOMESCO Finland

Body CT examination

1.6

9.4

201

1267

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.1

9.4

436

RJ420, ,

NOMESCO Finland

5.2

9.4

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

4.9

9.3

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

9.3

566

4399

6BA02, ,

NOMESCO Finland

8.7

9.3

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.7

9.3

179

1099

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.9

9.3

107

563

R02

ICPC

Shortness of breath/dyspnoea

1.5

9.2

280

1913

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

3.8

9.2

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

9.2

1584

14210

C07AB02

ATC

metoprolol; systemic

1.4

9.2

407

2996

A28

ICPC

Limited function/disability NOS

1.5

9.2

332

2352

M02AA10

ATC

ketoprofen; topical

1.5

9.2

357

2566

XKD00

NOMESCO Finland

Uroflowmetry

1.6

9.1

203

1292

A04

ICPC

Weakness/tiredness general

1.5

9.1

328

2321

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

9.1

144

836

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.1

9.1

435

K02.1

ICD-10 Finland

Caries of dentine

1.3

9.1

1358

11954

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

4.0

9.1

RT172, ,

NOMESCO Finland

15.6

9.0

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.2

9.0

363

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.1

9.0

383

N06AX16

ATC

venlafaxine; oral

1.5

8.9

343

2459

D07AA02

ATC

hydrocortisone; topical

1.5

8.9

307

2154

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.9

8.9

144

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

24.1

8.9

PJA10

NOMESCO Finland

Exploration of lymph nodes

3.3

8.9

102

UJD02

NOMESCO Finland

Gastroscopy

1.9

8.9

107

571

SFA10

NOMESCO Finland

One-surface restoration

1.3

8.9

1271

11111

C09CA06

ATC

candesartan; oral

1.4

8.9

527

4076

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.2

8.8

339

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.1

8.8

372

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

4.9

8.8

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

4.5

8.8

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

3.6

8.8

F45.0

ICD-10 Finland

Somatization disorder

4.7

8.8

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

8.8

110

595

H57.1

ICD-10 Finland

Ocular pain

2.0

8.8

482

A06AC51

ATC

ispaghula, combinations; oral

1.9

8.8

114

624

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

8.8

294

2052

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.7

8.7

G62.8

ICD-10 Finland

Other specified polyneuropathies

3.9

8.7

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

14.1

8.7

L93.2

ICD-10 Finland

Other local lupus erythematosus

50.2

8.7

TQW80

NOMESCO Finland

Local dermatologic skincare

2.3

8.7

271

D06BX01

ATC

metronidazole; topical

1.5

8.7

265

1814

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

8.7

327

2336

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.4

8.7

228

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.1

8.6

369

ZX108

NOMESCO Finland

Inhalation

4.4

8.6

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.3

8.6

272

DHA10

NOMESCO Finland

Biopsy of cavity of nose

4.0

8.6

H15.1

ICD-10 Finland

Episcleritis

2.8

8.6

147

N07AA02

ATC

pyridostigmine; systemic

4.6

8.6

RT160, ,

NOMESCO Finland

16.3

8.5

K13.78

ICD-10 Finland

Other change in the oral mucosa

2.3

8.5

267

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

8.5

640

5127

A06AD11

ATC

lactulose; oral

1.5

8.5

295

2073

M35.4

ICD-10 Finland

Diffuse (eosinophilic) fasciitis

27.6

8.5

R50.1

ICD-10 Finland

Persistent fever

20.1

8.5

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

2.0

8.4

420

4430A

ICD-9 Finland

Other peripheral vascular disease, Raynaud's syndrome

90.4

8.4

C02KX02

ATC

ambrisentan; oral

90.4

8.4

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

8.4

130

751

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

2.9

8.4

138

L50.0

ICD-10 Finland

Allergic urticaria

2.2

8.4

327

M30.0

ICD-10 Finland

Polyarteritis nodosa

12.8

8.4

R50.0

ICD-10 Finland

Fever with chills

12.8

8.4

E000003, ,

ATC

1.9

8.4

102

547

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

4.5

8.4

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.8

8.3

N16.4*M35.0

ICD-10 Finland

Sjögren's syndrome with renal tubulo-interstitial disorders

+∞

8.3

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

8.3

120

679

R03DC03

ATC

montelukast; oral

1.4

8.3

397

2960

XA800

NOMESCO Finland

Neuropsychological investigation

2.0

8.3

471

L12

ICPC

Hand/finger symptom/complaint

1.4

8.3

366

2691

K11.7

ICD-10 Finland

Disturbances of salivary secretion

9.5

8.3

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

8.3

119

673

J01FA01

ATC

erythromycin; systemic

1.5

8.3

317

2271

R03BB04

ATC

tiotropium bromide; inhalant

1.6

8.3

197

1276

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.2

8.2

290

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

7.1

8.2

SPAT1325

SPAT

Vaccination

1.3

8.2

707

5766

TNH31

NOMESCO Finland

Prefabricated orthosis, ankle or foot

3.2

8.2

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

8.2

1085

9358

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

7.5

8.1

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.7

8.1

159

980

R4180

NOMESCO Finland

Podiatric therapy

3.0

8.1

119

ACC51

NOMESCO Finland

Release of median nerve

1.6

8.1

177

1123

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

8.1

1276

11239

TPX00

NOMESCO Finland

Biopsy of artery or vein

17.2

8.1

H16.9

ICD-10 Finland

Keratitis, unspecified

2.7

8.1

158

R35

ICD-10 Finland

Polyuria

1.8

8.1

123

708

QDH05

NOMESCO Finland

Correction of deformity of toe nail

8.9

8.0

L01CB

ATC

Podophyllotoxin derivatives

8.9

8.0

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

8.0

208

1374

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

6.3

8.0

A02BA03

ATC

famotidine; systemic

2.0

8.0

387

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.0

8.0

463

R55

ICD-10 Finland

Syncope and collapse

1.6

8.0

213

1415

K11.9

ICD-10 Finland

Disease of salivary gland, unspecified

4.1

8.0

NG1DA

NOMESCO Finland

X-ray of knees

2.5

8.0

188

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

8.0

274

1921

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.9

8.0

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.5

8.0

104

Kela drug reimbursment

Thyroid insufficiency

1.6

8.0

179

1143

C01DA14

ATC

isosorbide mononitrate; oral

1.5

7.9

255

1763

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.4

7.9

H16.0

ICD-10 Finland

Corneal ulcer

1.8

7.9

107

593

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

4.3

7.9

TPH04, ,

SPAT

4.3

7.9

M19.2

ICD-10 Finland

Other secondary arthrosis

3.0

7.9

115

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

7.9

267

1866

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

4.6

7.9

B35.3

ICD-10 Finland

Tinea pedis

1.9

7.9

494

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

7.8

7.9

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

7.8

630

5085

N03AX11

ATC

topiramate; oral

2.2

7.8

310

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.7

7.8

155

B34.9

ICD-10 Finland

Viral infection, unspecified

2.2

7.8

297

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.3

7.8

252

L04.0

ICD-10 Finland

Acute lymphadenitis of face, head and neck

3.2

7.8

L52

ICD-10 Finland

Erythema nodosum

3.8

7.8

TEG00

NOMESCO Finland

Punction of mandibular joint

10.8

7.8

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.4

7.8

221

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

7.8

130

769

R01AD12

ATC

fluticasone furoate; nasal

1.3

7.7

745

6161

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

3.7

7.7

EKA10

NOMESCO Finland

iopsy of buccal mucosa

2.4

7.7

228

A02BC04

ATC

rabeprazole; oral

1.5

7.7

211

1410

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

7.7

153

947

B01AC27

ATC

selexipag; oral

45.1

7.7

J99.1*M33.2

ICD-10 Finland

Respiratory disorders in polymyositis

45.1

7.7

I50.0

ICD-10 Finland

Congestive heart failure

1.8

7.7

122

710

G47.3

ICD-10 Finland

Sleep apnoea

1.4

7.7

433

3316

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

7.7

242

1668

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

3.0

7.7

112

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

3.4

7.7

3AC01, ,

NOMESCO Finland

3.3

7.7

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

7.6

885

7494

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.1

7.6

347

GDG10

NOMESCO Finland

Bilateral transplantation of lung

18.4

7.6

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

7.6

102

565

G04AC01, ,

ATC

2.0

7.6

388

M79.3

ICD-10 Finland

Panniculitis, unspecified

8.0

7.6

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.7

7.6

146

M05.2

ICD-10 Finland

Rheumatoid vasculitis

25.1

7.6

N06AG02

ATC

moclobemide; oral

1.9

7.5

530

M12.3

ICD-10 Finland

Palindromic rheumatism

8.9

7.5

B01AC04

ATC

clopidogrel; oral

1.5

7.5

280

1993

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

7.5

177

1143

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

7.5

445

R07.1

ICD-10 Finland

Chest pain on breathing

2.7

7.5

141

S01

ICPC

Pain/tenderness of skin

1.8

7.5

102

568

GD2SN

NOMESCO Finland

Lung ventilation SPECT

3.7

7.5

ZZA00

NOMESCO Finland

Split skin graft

2.2

7.5

270

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.0

7.5

370

K29.7

ICD-10 Finland

Gastritis, unspecified

2.0

7.4

398

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.2

7.4

264

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

4.4

7.4

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

2.5

7.4

171

J99.1*M32.1

ICD-10 Finland

Respiratory disorders in systemic: lupus erythematosus

80.3

7.4

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

80.3

7.4

N35.1

ICD-10 Finland

Postinfective urethral stricture, not elsewhere classified

80.3

7.4

G73.7*M34.8

ICD-10 Finland

Myopathy in scleroderma

80.3

7.4

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

7.4

150

934

E000007, ,

ATC

1.7

7.4

126

749

SPAT1153

SPAT

Removal of sutures

1.3

7.4

668

5473

R30.0

ICD-10 Finland

Dysuria

1.9

7.4

505

M31.6

ICD-10 Finland

Other giant cell arteritis

7.7

7.4

M05.3

ICD-10 Finland

Rheumatoid arthritis with involvement of other organs and systems

13.4

7.4

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

7.4

647

5280

EHA10

NOMESCO Finland

Biopsy of palate

4.0

7.3

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

7.3

1238

10944

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

2.4

7.3

209

ND2AE

NOMESCO Finland

Hand and fingers ultrasound examination

6.8

7.3

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

7.3

192

1274

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.9

7.3

465

XQ802

NOMESCO Finland

Epicutan test

1.8

7.2

100

559

SFA00

NOMESCO Finland

Small restoration

1.4

7.2

308

2248

R63.4

ICD-10 Finland

Abnormal weight loss

1.9

7.2

423

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

15.8

7.2

7102B

ICD-9 Finland

Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM SECUNDARIUM]

15.8

7.2

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.2

7.2

248

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.3

7.2

236

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

7.1

305

2227

R04.2

ICD-10 Finland

Haemoptysis

2.1

7.1

315

R05

ICPC

Cough

1.3

7.1

537

4291

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

6.6

7.1

QDA99

NOMESCO Finland

Other local destruction of skin of lower limb

7.9

7.1

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.4

7.1

265

1889

F48.0

ICD-10 Finland

Neurasthenia

12.0

7.1

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

6.0

7.1

N03AX09

ATC

lamotrigine; oral

1.8

7.1

110

638

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

7.0

177

1161

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

7.0

122

729

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

7.0

101

572

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

2.5

7.0

164

SPAT1260

SPAT

Consultation of another employee

1.4

7.0

368

2783

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

2.9

7.0

107

SFA30

NOMESCO Finland

Three-surface restoration

1.3

7.0

935

8030

WVA20

NOMESCO Finland

Medicine administration

2.2

7.0

258

SFA20

NOMESCO Finland

Two-surface restoration

1.2

7.0

1348

12069

R06AX22

ATC

ebastine; oral

1.4

7.0

406

3121

R06AX27

ATC

desloratadine; oral

1.3

6.9

672

5548

A01AB10

ATC

natamycin; local oral

2.0

6.9

360

M54.2

ICD-10 Finland

Cervicalgia

1.5

6.9

182

1207

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.2

6.9

253

L95.8

ICD-10 Finland

Other vasculitis limited to skin

7.5

6.9

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.5

6.9

182

1208

N04BC05

ATC

pramipexole; oral

1.6

6.9

164

1063

R06.4

ICD-10 Finland

Hyperventilation

2.6

6.9

142

N05BA01

ATC

diazepam; systemic, rectal

1.4

6.9

280

2027

FN1AD

NOMESCO Finland

CT of coronary arteries

2.5

6.8

172

RT171, ,

NOMESCO Finland

8.3

6.8

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

8.3

6.8

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.4

6.8

197

Z94.2

ICD-10 Finland

Lung transplant status

11.0

6.8

XG466

NOMESCO Finland

Sleep oxymetry

2.1

6.8

301

H19.3

ICD-10 Finland

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

9.3

6.8

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.5

6.8

173

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.5

6.8

161

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

6.1

6.8

S22

ICPC

Nail symptom/complaint

1.6

6.8

136

846

G73.7*M32.1

ICD-10 Finland

Myopathy in systemic lupus erythematosus

40.2

6.8

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.8

6.7

499

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.6

6.7

150

958

R5110, ,

SPAT

1.6

6.7

135

840

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.4

6.7

180

S32.7

ICD-10 Finland

Multiple fractures of lumbar spine and pelvis

3.4

6.7

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

6.7

878

7515

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

6.7

500

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

6.7

150

959

L94.8

ICD-10 Finland

Other specified localized connective tissue disorders

22.6

6.7

SPAT1210

SPAT

Application of cast or individual aid

1.8

6.7

537

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.9

6.6

472

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

6.6

128

788

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

6.6

269

1947

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

5.5

6.6

WZC30

NOMESCO Finland

Teaching

1.4

6.6

326

2441

Z00.0

ICD-10 Finland

General medical examination

1.3

6.6

400

3094

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.9

6.6

100

-, ,

ICD-10 Finland

2.2

6.6

245

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

6.6

521

4186

N35.0

ICD-10 Finland

Post-traumatic urethral stricture

12.3

6.6

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.3

6.6

213

J01FA09

ATC

clarithromycin; systemic

1.3

6.6

708

5918

J37.0

ICD-10 Finland

Chronic laryngitis

2.0

6.6

374

XCH00

NOMESCO Finland

Eye pressure measurement

1.8

6.6

525

183

Kela drug reimbursment

Lamotrigin and topiramate

3.3

6.6

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.1

6.5

259

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

6.5

499

3990

S20.2

ICD-10 Finland

Contusion of thorax

1.8

6.5

102

593

L03

ICPC

Low back symptom/complaint

1.3

6.5

628

5177

R03BA02

ATC

budesonide; inhalant

1.3

6.5

406

3154

S70

ICPC

Herpes zoster

2.1

6.5

293

L60.0

ICD-10 Finland

Ingrowing nail

1.7

6.5

104

609

L71.9

ICD-10 Finland

Rosacea, unspecified

2.1

6.5

300

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.4

6.5

183

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

2.4

6.5

183

R03BA01

ATC

beclometasone; inhalant

1.4

6.5

304

2257

TQW40

NOMESCO Finland

Remowal of suture of skin

1.6

6.5

149

959

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.5

6.4

153

K12.00

ICD-10 Finland

Recurrent oral aphthae

2.5

6.4

153

H02AA02

ATC

fludrocortisone; oral

3.5

6.4

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

3.5

6.4

D84.19

ICD-10 Finland

Unspecified defect in the complement system

70.0

6.4

I32.8*M32.1

ICD-10 Finland

Pericarditis (in) systemic lupus erythematosus

70.0

6.4

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

2.9

6.4

D69.0

ICD-10 Finland

Allergic purpura

3.4

6.4

K92.1

ICD-10 Finland

Melaena

1.8

6.4

566

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

14.3

6.4

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.6

6.4

130

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.8

6.4

478

U71

ICPC

Cystitis/urinary infection other

1.6

6.4

162

1066

L01

ICPC

Neck symptom/complaint

1.4

6.4

357

2727

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

2.4

6.4

166

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.3

6.4

197

EBB10

NOMESCO Finland

Insertion of dental implant

2.6

6.4

142

EB1WA, ,

NOMESCO Finland

3.7

6.4

H25.8

ICD-10 Finland

Other senile cataract

1.5

6.4

196

1345

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

6.4

551

4479

U07

ICPC

Urine symptom/complaint other

1.6

6.3

153

995

A08

ICPC

Swelling

1.7

6.3

106

628

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

6.3

372

L29.9

ICD-10 Finland

Pruritus, unspecified

2.0

6.3

351

G50.1

ICD-10 Finland

Atypical facial pain

2.3

6.3

204

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

6.3

206

1430

XF622

NOMESCO Finland

Measurement of minute volume of heart

11.0

6.3

M25.1

ICD-10 Finland

Fistula of joint

11.0

6.3

7199L

ICD-9 Finland

Other and unspecified disorder of joint, Unspecified disorder of joint[MB ARTICULI NUD,USEAT NIVELET]

11.0

6.3

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

6.3

266

1939

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.0

6.3

324

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.4

6.3

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

6.3

332

2514

J99.1*M33.9

ICD-10 Finland

Respiratory disorders in dermatopolymyositis

+∞

6.3

M33.0

ICD-10 Finland

Juvenile dermatomyositis

+∞

6.3

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

6.2

168

1120

M01AB05

ATC

diclofenac; systemic, rectal

1.2

6.2

1536

14040

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.2

6.2

218

M31.0

ICD-10 Finland

Hypersensitivity angiitis

26.7

6.2

K29

ICPC

Cardiovascular sympt/complt other

1.9

6.2

424

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

6.2

343

2613

M81.8

ICD-10 Finland

Other osteoporosis

2.9

6.2

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

2.6

6.2

138

C08CA13

ATC

lercanidipine; oral

1.4

6.2

288

2134

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

2.5

6.2

150

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.0

6.2

326

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

6.2

701

5888

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

6.2

384

2979

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

4.0

6.2

XQ800

NOMESCO Finland

Prick test

1.5

6.2

176

1189

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

3.5

6.2

SXA10

NOMESCO Finland

Oral mucosal sampling

2.7

6.2

121

R06AE09

ATC

levocetirizine; oral

1.4

6.1

328

2486

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.6

6.1

127

K59.0

ICD-10 Finland

Constipation

1.7

6.1

111

673

SPF10

NOMESCO Finland

Demanding reparation of dental prosthesis

2.5

6.1

151

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.5

6.1

151

K30

ICD-10 Finland

Functional dyspepsia

1.4

6.1

248

1796

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

2.2

6.1

227

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.4

6.1

170

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

1.8

6.1

457

KMAK, ,

NOMESCO Finland

1.2

6.1

1167

10384

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

8.6

6.1

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

2.2

6.0

208

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.8

6.0

472

M80

ICD-10 Finland

Osteoporosis with pathological fracture

3.1

6.0

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.7

6.0

106

637

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.5

6.0

163

1088

M01AH03

ATC

valdecoxib; oral

1.6

6.0

127

800

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

6.7

6.0

40199

ICD-8 Finland

Essential benign hypertension

2.5

6.0

146

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.7

6.0

105

630

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3006315) Basophils [#/volume] in Blood

2068

10697

5.98

312.96

12.7

5.7

0.04

e9/l

1.79

1963

9257

(3001604) Monocytes [#/volume] in Blood

2065

10669

5.96

312.96

12.7

5.7

0.55

0.56

e9/l

1.04

1962

9244

(3005719) IgG [Mass/volume] in Serum or Plasma

700

1567

5.78

308.70

3.8

2.7

11.78

10.44

g/l

9.01

670

1421

(3039162) Centromere protein B Ab [Units/volume] in Serum

512

269

23.58

307.65

1.8

1.2

61.26

48.13

u/ml

0.29

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

822

579

20.49

307.65

1.9

1.2

27.02

3.61

u/ml

13.82

341

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1023

625

26.70

307.65

3.5

1.5

0.19

0.24

g/l

21.64

994

589

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

304

160

21.44

307.65

1.4

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

304

160

21.44

307.65

1.4

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

816

867

13.38

307.65

1.8

1.2

4.02

1.01

u/ml

2.52

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

304

160

21.44

307.65

1.4

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

820

570

20.75

307.65

1.9

1.2

13.19

2.62

u/ml

3.32

212

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

860

680

18.59

307.65

3.7

1.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

301

159

21.34

307.65

1.4

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2049

10028

6.35

307.65

12.7

6.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

301

159

21.34

307.65

1.4

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

301

159

21.34

307.65

1.4

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

1397

3050

8.94

307.65

2.2

1.3

1180.53

539.90

titre

23.82

793

623

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

839

628

19.44

307.65

1.8

1.2

31.21

26.08

u/ml

0.22

120

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1024

650

25.69

307.65

3.5

1.5

1.08

1.20

g/l

14.65

998

613

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

630

457

17.99

307.65

1.7

1.1

22.77

0.55

u/ml

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

672

477

18.78

307.65

1.8

1.2

56.73

32.68

u/ml

1.98

160

(3023420) DNA double strand Ab [Units/volume] in Serum

344

236

16.70

307.65

3.2

1.3

36.23

26.82

iu/ml

0.61

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

714

448

21.76

307.65

1.8

1.2

4.11

3.85

u/ml

0.04

111

(3013115) Eosinophils [#/volume] in Blood

2087

11093

5.90

298.93

13.1

5.9

0.17

0.19

e9/l

6.99

1994

9746

(3019198) Lymphocytes [#/volume] in Blood

2071

10997

5.74

295.34

12.8

5.7

1.68

1.93

e9/l

22.88

1986

9756

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

203

25.27

285.69

1.2

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

155

58.88

276.34

1.9

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2148

12438

5.66

255.44

15.2

8.9

3.78

4.00

e9/l

5.44

2037

10868

(3022096) Basophils/100 leukocytes in Blood

1860

9710

4.40

254.13

13.1

5.8

0.71

0.68

1.36

1816

9045

(3006504) Eosinophils/100 leukocytes in Blood

1884

10022

4.39

248.08

13.1

5.8

2.73

2.81

0.88

1844

9357

(3019069) Monocytes/100 leukocytes in Blood

1888

10085

4.38

246.44

13.6

6.1

9.12

8.34

24.47

1845

9435

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1395

6152

3.81

240.82

3.5

2.1

137.61

197.74

u/l

2.26

1337

5793

(3018010) Neutrophils/100 leukocytes in Blood

1894

10239

4.32

240.45

12.7

5.6

57.96

56.89

3.58

1851

9592

(3004616) Nuclear Ab [Presence] in Serum

265

262

11.17

239.99

1.8

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

441

813

6.35

235.45

1.5

22.70

10.49

u/ml

0.68

(3002030) Lymphocytes/100 leukocytes in Blood

1897

10378

4.25

233.88

13.3

5.8

27.24

28.51

6.20

1856

9733

(3028026) IgM [Mass/volume] in Serum or Plasma

536

1234

5.24

223.96

2.0

1.8

1.46

1.44

g/l

0.07

509

1121

(3038026) Centromere Ab [Units/volume] in Serum

207

171

13.09

210.37

1.7

1.1

36.57

82.47

u/ml

1.01

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

203

168

13.04

206.02

1.6

1.1

52.96

57.88

u/ml

0.08

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

183

127

15.45

205.69

2.1

1.5

6.18

6.07

u/l

0.05

163

106

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

202

167

13.05

205.13

1.6

1.1

84.00

38.25

u/ml

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

197

161

13.18

201.43

1.6

1.1

26.51

2.40

u/ml

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

358

638

6.37

196.51

2.0

1.6

642.86

221.67

titre

1.54

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

997

4085

3.37

182.03

1.5

1.3

42.41

31.97

iu/ml

1.14

425

1334

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

934

3919

3.19

160.28

1.4

1.3

8.48

11.22

u/ml

0.75

365

1539

(3013707) Erythrocyte sedimentation rate by Westergren method

2280

16050

5.04

157.62

11.1

4.0

14.74

11.93

mm/h

15.01

2232

14905

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1618

9300

3.03

155.61

3.1

2.3

80.47

77.70

nmol/l

3.81

1537

8409

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

221

334

7.15

141.16

1.5

1.2

4.53

4.57

u/ml

0.01

122

133

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1101

5404

2.83

137.89

3.6

2.9

917.80

1198.35

ng/l

2.28

985

4565

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2257

16306

4.39

137.49

13.1

7.4

74.12

77.33

u/l

2.90

2225

15363

(42529582) MDA5 Ab [Presence] in Serum by Line blot

101

21.42

134.37

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

101

21.42

134.37

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

101

21.42

134.37

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

101

21.42

134.37

1.2

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

210

319

7.09

133.38

2.4

1.6

0.82

0.73

g/l

0.38

169

238

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

217

343

6.82

132.77

1.6

1.2

4.62

4.44

u/ml

0.04

120

105

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

175

226

8.24

128.16

2.5

2.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

103

18.15

127.16

2.0

1.4

7.70

8.77

ug/l

1.20

103

(3035350) Ketones [Presence] in Urine by Test strip

1686

10543

2.78

127.08

6.1

3.7

0.00

estimate

0.99

365

2071

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1664

10339

2.76

127.00

7.6

6.4

1.22

mmol/l

1.34

1466

8816

(3037467) Urinalysis macro (dipstick) panel - Urine

2096

14725

3.40

126.99

8.4

4.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

258

506

5.56

126.50

1.6

1.4

12.27

22.96

iu/ml

—

(3009261) Glucose [Presence] in Urine by Test strip

1697

10666

2.77

126.27

6.2

3.7

0.00

0.01

estimate

1.32

352

1921

(3021601) Nitrite [Presence] in Urine by Test strip

1670

10568

2.69

119.79

8.1

5.0

0.00

estimate

0.38

354

1953

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

194

310

6.69

117.25

1.7

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

913

4372

2.70

115.86

1.8

1.4

2.48

2.28

g/l

2.52

668

2667

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

207

358

6.21

115.69

1.4

1.3

408.57

71.43

titre

—

(3017181) Myelocytes/100 leukocytes in Blood

507

1789

3.29

111.99

5.9

3.9

0.71

0.95

1.54

191

566

(3020630) Protein [Mass/volume] in Serum or Plasma

463

1554

3.42

110.83

2.0

2.8

68.08

66.71

g/l

2.94

435

1414

(3004588) Protein electrophoresis panel - Serum or Plasma

413

1295

3.61

109.85

1.7

2.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1510

9349

2.51

109.29

6.6

5.7

1.22

mmol/l

1.35

1428

8535

(3028192) IgG subclass 2 [Mass/volume] in Serum

150

195

8.11

109.06

1.9

1.5

2.79

2.89

g/l

0.25

119

132

(3024139) IgG subclass 3 [Mass/volume] in Serum

149

195

8.05

107.71

1.9

1.5

0.39

0.38

g/l

0.15

118

132

(4062490) Immunoglobulin typing, IgG

151

201

7.92

107.60

2.0

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

149

196

8.01

107.24

1.9

1.5

7.72

6.73

g/l

1.13

117

133

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

277

668

4.53

105.97

1.6

1.5

8.28

0.12

iu/ml

0.48

129

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

271

643

4.60

105.81

2.7

2.3

162.59

707.56

ug/l

1.05

249

598

(3021440) Promyelocytes/100 leukocytes in Blood

481

1709

3.24

104.51

6.0

4.0

0.02

0.13

5.70

163

485

(3025159) Blasts/100 leukocytes in Blood

462

1619

3.26

102.58

6.1

4.0

0.01

0.50

1.00

143

399

(3018418) pH of Serum or Plasma

1113

6170

2.43

100.35

4.3

3.8

7.39

7.40

1.69

196

1155

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

126

156

8.45

95.28

2.2

1.8

2.98

3.76

mg/l

1.48

121

149

(3018095) Leukocytes [#/volume] in Urine

1238

7311

2.35

95.17

5.4

3.5

75.66

90.55

e6/l

0.42

915

5015

(3015736) pH of Urine

1378

8533

2.34

94.60

5.3

3.4

5.91

5.89

0.09

676

(3002179) Metamyelocytes/100 leukocytes in Blood

450

1639

3.12

93.00

5.7

3.8

0.32

0.69

5.72

155

486

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

311

901

3.79

92.34

1.6

2.0

40.04

39.10

u/l

0.34

282

809

(3011397) Hemoglobin [Presence] in Urine by Test strip

941

4985

2.41

92.20

5.5

3.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

527

2107

2.89

92.14

3.3

4.3

241.33

248.36

u/l

0.48

498

1994

(3021589) Normoblasts [#/volume] in Blood

1461

9496

2.26

86.37

15.9

9.0

0.00

e9/l

0.61

1309

7734

(3000850) Epithelial cells [#/volume] in Urine

822

4254

2.38

83.35

3.5

2.5

4.28

6.99

e6/l

8.67

762

3805

(21491868) Cryoglobulin [Mass/volume] in Serum

11.37

82.58

1.2

1.3

0.16

0.28

g/l

—

(3002582) Erythrocytes [#/volume] in Urine

1037

6102

2.18

75.55

4.4

3.1

71.15

69.80

e6/l

0.01

872

4619

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

111

8.85

75.14

1.3

1.1

7.75

31.62

u/ml

0.45

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

215

569

4.03

72.09

1.6

2.1

10.46

11.75

mg/l

1.16

201

525

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

239

685

3.75

71.55

1.7

2.6

12.39

10.12

g/l

6.23

221

615

(3034770) Mitochondria Ab [Titer] in Serum

214

569

4.01

71.28

1.3

1.2

801.43

1010.00

titre

0.23

(3036481) Cortisol [Moles/volume] in Serum or Plasma

481

2076

2.62

70.93

2.1

367.76

371.87

nmol/l

0.12

457

1891

(3024561) Albumin [Mass/volume] in Serum or Plasma

1354

8975

2.09

70.61

5.8

4.6

35.28

35.78

g/l

2.63

1291

8384

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

126

7.96

70.36

1.4

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

249

746

3.59

69.74

1.7

2.5

3.64

3.59

g/l

0.23

232

680

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

249

747

3.59

69.59

1.7

2.5

7.30

7.41

g/l

0.46

232

680

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

248

747

3.57

68.87

1.7

2.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

209

563

3.95

68.31

1.3

1.2

113.75

95.38

titre

0.27

(40758558) Short blood count panel - Blood

938

5502

2.12

67.01

10.4

6.5

—

(36304419) Bacteria [Presence] in Urine

934

5504

2.10

65.60

4.1

2.9

—

(3030467) Casts [#/volume] in Urine by Automated count

947

5617

2.09

65.30

4.4

3.0

0.20

0.40

e6/l

5.65

791

4223

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

208

577

3.84

65.16

1.7

2.5

0.03

0.01

g/l

0.22

198

533

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

235

711

3.54

64.72

1.7

2.6

3.10

2.95

g/l

1.32

218

644

(3022948) Iron [Moles/volume] in Serum or Plasma

628

3180

2.29

64.53

2.7

2.3

11.91

13.32

umol/l

5.67

594

2960

(3026493) Urate [Moles/volume] in Serum or Plasma

897

5234

2.10

64.44

2.9

2.4

2290.08

5204.08

umol/l

2.19

812

4599

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

134

7.33

64.13

1.3

1.1

1.13

1.03

ratio

2.14

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

555

2683

2.37

63.42

2.7

2.4

20.54

22.90

3.86

481

2298

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

208

594

3.72

62.42

1.7

2.4

36.95

38.05

g/l

1.53

191

526

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

218

649

3.58

61.47

1.7

2.6

0.64

0.83

g/l

0.30

200

571

(3004789) Transferrin [Mass/volume] in Serum or Plasma

578

2887

2.30

60.95

2.6

2.3

2.34

2.37

g/l

0.71

548

2673

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

652

3424

2.22

60.87

3.2

2.6

0.89

1.17

e6/l

1.43

439

1909

(3017143) Hepatitis C virus Ab [Presence] in Serum

505

2396

2.38

59.89

1.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1520

10889

1.98

59.58

6.8

6.1

9.63

10.80

umol/l

6.99

1461

10329

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

890

5316

2.04

58.88

2.9

2.2

3.00

2.94

mg/l

0.31

792

4540

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

189

528

3.79

58.50

1.8

2.6

0.00

g/l

-0.00

180

492

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

190

534

3.76

58.30

1.8

2.6

0.00

g/l

-0.00

180

493

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

197

578

3.61

56.70

2.8

—

(3023368) Bacteria identified in Blood by Culture

854

5092

2.02

56.25

5.3

4.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

362

1525

2.60

55.17

3.2

2.9

132.62

183.66

ng/l

1.94

339

1375

(3011412) CD3 cells [#/volume] in Blood

104

188

5.72

55.15

2.2

2.3

1.04

1.29

e9/l

1.66

169

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

363

1542

2.58

54.34

2.4

33.74

24.24

au/ml

0.67

126

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

340

1403

2.64

53.98

1.3

36.26

49.19

au/ml

0.67

(3029937) Albumin [Presence] in Urine by Test strip

912

5652

1.96

53.10

7.1

4.1

0.00

estimate

1.28

354

1925

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

144

6.29

51.65

1.4

1.1

208.44

131.43

titre

0.49

(40761535) Cells panel - Urine sediment

380

1692

2.46

51.31

5.4

3.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

437

2080

2.33

50.75

3.6

2.5

1.72

1.83

1.34

407

1851

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1189

8128

1.87

50.57

6.6

3.8

—

(3042936) Bacteria identified in Isolate by Culture

545

2846

2.16

50.48

2.4

1.9

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

153

421

3.80

48.30

4.2

3.6

59.15

57.58

0.81

153

421

(3022217) INR in Platelet poor plasma by Coagulation assay

1267

9012

1.81

45.79

16.8

13.4

1.22

1.20

inr

0.30

385

2657

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

141

5.98

45.78

2.2

2.0

—

(40768443) Skin Pathology biopsy report

241

912

2.81

45.01

1.3

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1358

9906

1.80

44.66

3.6

2.8

117.03

103.01

ug/l

1.15

1280

9216

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

573

3195

2.02

43.85

2.2

1.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1788

14208

1.87

43.82

6.2

4.5

3519.94

2174.55

e6/l

0.33

188

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

8.19

42.75

1.3

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

221

822

2.85

42.57

2.4

1.8

1.48

1.55

g/l

0.42

199

712

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

138

388

3.70

42.18

6.0

4.9

304.50

333.57

iu/ml

0.04

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

808

5116

1.85

41.93

1.4

1.3

1.97

1.56

u/ml

0.34

214

1370

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1084

7518

1.77

41.32

4.5

3.4

26.83

48.02

ng/l

1.23

752

4766

(3019150) Specific gravity of Urine by Refractometry

742

4596

1.87

41.16

6.8

4.1

1.01

1.02

kg/l

1.51

658

(3021879) Hepatitis B virus core Ab [Presence] in Serum

336

1571

2.31

40.09

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

151

467

3.37

39.90

1.7

7454.07

10886.19

e6/l

0.80

117

338

(3037756) Immunofixation for Serum or Plasma

138

403

3.56

39.85

1.3

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

457

2425

2.08

39.67

2.1

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2395

21455

2.97

39.33

26.9

13.2

17.55

21.72

mg/l

13.03

2133

16835

(3000494) Fungus identified in Specimen by Culture

462

2480

2.05

38.80

1.8

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

140

5.49

38.41

1.7

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1173

8448

1.72

38.13

2.1

2.0

97.42

96.85

pmol/l

0.15

628

4228

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

128

5.68

37.74

2.0

2.4

410.53

572.53

e6/l

1.14

106

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

122

5.79

37.43

2.0

2.5

0.17

0.20

e9/l

0.79

105

(3034426) Prothrombin time (PT)

7.43

37.35

1.3

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

139

433

3.34

36.29

1.3

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

113

307

3.81

36.28

2.7

2.9

402.33

1662.94

u/ml

—

(3021960) Folate [Moles/volume] in Serum or Plasma

740

4732

1.79

36.17

1.6

1.5

20.19

21.19

nmol/l

1.10

653

4055

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

563

3317

1.90

35.80

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

7.35

35.64

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

320

1538

2.24

35.55

2.8

2.6

68.86

71.12

e9/l

0.51

236

1159

(3048689) Calprotectin [Mass/mass] in Stool

488

2754

1.96

35.26

2.2

148.75

117.56

ug/g

0.75

395

2182

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

165

579

2.98

35.24

1.9

3.7

34.41

50.42

mg/l

0.78

136

479

(3034860) Kappa light chains.free [Mass/volume] in Serum

164

578

2.96

34.75

1.9

3.7

44.26

62.37

mg/l

0.73

136

477

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

153

524

3.04

34.09

1.5

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

187

715

2.74

34.06

2.3

2.0

1.93

2.05

ug/l

0.06

159

631

(3029075) Extractable nuclear Ab panel - Serum

7.83

34.05

1.2

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

631

3925

1.81

33.42

1.7

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1031

7355

1.68

33.35

3.4

3.3

2.34

2.36

mmol/l

4.59

916

6542

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

745

4872

1.75

33.19

2.0

1.8

1.11

1.07

mg/l

0.15

599

3710

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

992

7019

1.68

33.02

4.4

3.1

32.64

32.72

u/l

0.02

952

6670

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

939

6551

1.69

32.96

3.0

2.5

59.21

71.13

u/l

0.48

892

6053

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

158

562

2.93

32.92

1.9

3.7

1.33

1.62

ratio

0.38

(3026782) Osmolality of Urine

640

4025

1.79

32.54

4.2

2.8

505.11

525.55

mosm/kgh2o

1.72

568

3461

(40768797) Stomach Pathology biopsy report

511

3015

1.87

31.94

1.3

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

105

298

3.63

31.64

3.0

3.3

1.10

1.34

0.41

100

269

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

120

373

3.33

31.43

1.7

1.4

—

(3017732) Neutrophils [#/volume] in Blood

304

1505

2.16

31.19

3.5

2.9

3.88

5.26

e9/l

1.84

236

1254

(3019309) Folate [Moles/volume] in Red Blood Cells

589

3666

1.79

30.79

1.8

1.7

1194.06

1188.11

nmol/l

0.05

483

2771

(3045414) Leukocytes [Presence] in Urine

228

1012

2.38

30.37

2.0

1.9

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

361

1941

2.00

29.60

2.9

2.2

0.21

0.22

g/l

0.08

332

1820

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

522

3178

1.81

29.20

3.8

2.7

2.92

3.35

e6/l

0.36

310

1671

(3041096) Erythrocytes [Presence] in Urine by Automated

830

5746

1.66

29.19

5.8

3.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

442

2565

1.88

28.83

5.6

5.4

1.04

mmol/l

0.02

414

2371

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

393

2199

1.93

28.64

2.1

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1498

12014

1.60

28.38

5.9

4.5

6.38

6.61

mmol/l

4.27

1434

11189

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

118

5.09

28.02

2.7

2.8

47.37

44.99

0.38

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

159

4.43

27.66

1.3

1.2

—

titre

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

7.37

27.58

1.3

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

291

1485

2.08

27.45

1.4

1.3

184.98

179.13

u/ml

0.04

262

1362

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

388

2208

1.89

26.74

2.1

1.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

516

3245

1.74

25.45

4.1

3.3

0.81

0.82

mmol/l

1.81

482

3038

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

114

393

2.99

25.11

1.4

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

281

1465

2.03

24.92

1.8

1.7

—

(3042631) Mycobacterium sp identified in Specimen

246

3.54

24.90

2.8

2.6

—

(3021788) Differential panel - Synovial fluid

107

358

3.08

24.82

1.5

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

113

392

2.97

24.61

2.4

2.3

125.28

129.13

g/l

0.71

288

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

113

402

2.90

23.53

1.3

—

20.26

—

(21494814) CD8 cells/100 lymphocytes in Specimen

5.44

23.08

2.2

1.9

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

205

980

2.19

22.78

3.6

2.6

0.19

0.28

e6/l

0.80

198

945

(3026008) Bacteria identified in Urine by Culture

920

6832

1.54

22.72

3.6

3.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

267

3.30

22.60

1.7

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

103

357

2.96

22.48

1.3

129.25

113.06

u/ml

0.34

(40760888) Immunoglobulin light chains.free panel - Serum

115

429

2.76

21.93

1.9

3.9

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

145

607

2.47

21.91

2.7

2.5

183.37

181.44

0.09

138

581

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1985

17487

1.61

21.45

5.0

4.3

14.83

14.67

pmol/l

2.04

1871

16080

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

569

3824

1.63

21.38

4.6

3.5

268.51

300.03

ng/l

0.17

428

2769

(36660697) Celiac disease serology panel - Serum

317

1811

1.86

21.32

1.2

—

(3042951) Complement C1q Ab [Units/volume] in Serum

23.33

21.26

1.3

1.2

31.18

24.44

u/ml

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

100

352

2.92

21.24

1.7

1.4

—

(3008898) HLA-B27 [Presence]

178

827

2.24

21.21

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

193

927

2.17

21.18

1.1

1.67

0.96

u/ml

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

153

3.99

21.11

1.2

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

104

377

2.83

20.94

1.2

311.47

273.84

u/ml

0.33

228

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

109

409

2.74

20.57

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

461

2971

1.67

20.32

2.6

2.1

30.25

29.40

1.56

450

2880

(3020779) Urea [Moles/volume] in Serum or Plasma

287

1614

1.88

20.24

8.0

7.4

9.01

9.05

mmol/l

0.04

271

1539

(3008757) Leukocyte morphology finding [Identifier] in Blood

215

3.42

20.15

2.6

3.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

219

1127

2.03

20.03

1.7

1.6

—

(3019225) pH of Specimen

345

2072

1.77

19.59

4.4

4.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

181

3.60

19.46

2.4

3.1

57.74

55.56

0.31

157

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.51

19.31

2.3

1.9

—

(3003396) Base excess in Arterial blood by calculation

356

2167

1.75

19.28

8.2

7.6

1.11

1.13

mmol/l

0.03

287

1704

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

357

2175

1.75

19.27

8.2

7.5

4.97

5.08

kpa

1.24

335

2081

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

6.97

19.09

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

160

3.75

19.07

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

203

3.41

19.05

2.2

2.6

1.40

1.26

g/24h

0.13

(3027801) Oxygen [Partial pressure] in Arterial blood

356

2175

1.74

19.01

8.2

7.5

12.18

12.73

kpa

1.08

337

2080

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

139

615

2.33

18.58

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

119

493

2.48

18.40

1.8

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

273

1557

1.84

18.36

2.4

2.3

10.39

6.64

ug/l

0.59

227

1364

(3048929) Epstein Barr virus Ab [Presence] in Serum

143

650

2.27

17.95

1.3

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

281

1629

1.81

17.91

3.1

3.5

83.46

81.55

ng/l

0.11

255

1409

(3013512) EKG study

786

5870

1.49

17.90

4.5

3.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

285

1662

1.80

17.81

3.4

2.4

66.49

68.04

ml/min/173m2

0.28

128

658

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

142

647

2.27

17.73

2.6

2.2

97.75

92.58

2.12

137

618

(3016502) Oxygen saturation in Arterial blood

316

1902

1.76

17.73

8.8

8.1

95.54

95.94

0.69

302

1840

(40768804) Tissue Pathology biopsy report

1138

9148

1.44

17.59

2.3

2.1

—

(3023419) Bacteria identified in Sputum by Culture

277

2.95

17.54

3.0

2.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

378

2411

1.67

17.12

2.8

2.6

6.37

7.62

umol/l

0.95

328

2084

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

211

1135

1.94

16.97

4.6

3.5

5.10

5.19

kpa

0.95

204

1086

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

115

488

2.42

16.90

1.8

1.5

—

(3036489) Thrombin time

160

780

2.12

16.89

2.5

2.1

21.86

21.18

0.49

139

680

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

363

2.65

16.81

1.9

1.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

177

3.39

16.44

1.6

1.5

37.38

36.88

0.03

107

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

559

3950

1.53

16.36

2.8

2.9

2.44

2.45

mmol/l

0.49

504

3486

(3009343) pH of Capillary blood

206

1123

1.91

15.91

4.6

3.5

7.42

7.41

0.78

139

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2202

20275

1.64

15.85

6.2

5.1

1.90

2.02

mu/l

0.56

2089

18762

(3002385) Erythrocyte distribution width [Ratio]

2058

18664

1.54

15.74

28.7

15.8

15.15

14.84

1.71

2046

18332

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

164

830

2.04

15.68

2.2

1.9

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

100

412

2.49

15.68

1.1

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

280

1691

1.74

15.45

7.8

6.8

1.26

1.34

mmol/l

0.91

272

1650

(3021447) Carbon dioxide [Partial pressure] in Venous blood

282

1707

1.73

15.43

3.6

5.84

5.82

kpa

0.14

275

1660

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

199

1084

1.91

15.40

4.6

3.4

1.77

1.83

mmol/l

0.09

155

817

(3042111) Morphology [Interpretation] in Bone marrow Narrative

316

2.68

15.29

1.4

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

311

2.69

15.22

1.4

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

127

589

2.22

15.21

2.7

2.5

—

(3033658) Prothrombin time (PT) actual/Normal

706

5302

1.46

15.14

5.2

3.7

93.62

93.61

0.00

686

5154

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.97

14.99

1.6

1.3

—

(3002032) Base excess in Venous blood by calculation

278

1690

1.72

14.97

3.6

2.31

1.96

mmol/l

0.83

243

1434

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

121

554

2.24

14.96

1.8

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

355

2.56

14.94

1.2

—

(3044927) Protein electrophoresis panel - Urine

189

3.17

14.82

1.2

—

(3022621) pH of Urine by Test strip

240

1410

1.78

14.56

3.9

2.9

—

(3045424) Erythrocytes [Presence] in Urine

366

2.51

14.52

1.7

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

269

2.76

14.34

2.0

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

188

3.13

14.30

1.6

1.4

4399.26

89448.73

e6/l

1.21

131

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

148

747

2.04

14.26

2.1

1.8

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

237

2.88

14.19

1.7

1.6

49.25

57.30

0.80

148

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

265

2.77

14.17

1.6

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

131

635

2.12

14.06

1.1

4.49

u/ml

0.00

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2185

20203

1.58

14.04

20.4

12.1

84.16

82.55

ml/min/173m2

2.92

1965

16655

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

3.99

13.88

1.5

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

3.99

13.88

1.5

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

382

2.43

13.74

1.4

1.7

—

(3000060) B lymphocytes [#/volume] in Blood

5.46

13.53

2.0

2.1

130.71

145.00

e6/l

0.11

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

129

632

2.10

13.47

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

164

3.22

13.43

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

595

4410

1.46

13.42

1.7

13916954.18

32552875.98

pmol/l

0.60

503

3671

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2396

22743

1.91

13.41

20.9

10.2

24.76

24.81

u/l

0.05

2371

21980

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

308

2.58

13.40

1.6

1.4

—

(3044941) Cell count panel - Synovial fluid

314

2.56

13.39

1.4

1.5

—

(3000991) Gas panel - Venous blood

255

1566

1.70

13.19

9.1

8.3

—

(3019060) Gas panel - Arterial blood

209

1218

1.78

13.02

5.0

5.2

—

(3044889) 12 lead EKG panel

1669

14751

1.38

12.93

4.7

3.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

234

2.78

12.79

1.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

280

1789

1.63

12.42

9.6

8.4

118.65

120.45

g/l

0.86

271

1743

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

115

557

2.12

12.39

1.3

—

(3021901) Oxygen saturation in Capillary blood

303

2.52

12.32

4.1

2.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

121

599

2.07

12.31

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

4.29

12.19

1.1

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

4.06

12.11

1.5

1.2

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

8.69

11.99

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

4.56

11.89

2.2

2.7

—

(4035726) Immunohistochemistry procedure

294

1922

1.60

11.87

1.5

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

272

1748

1.62

11.78

1.3

1.2

137.74

150.29

iu/ml

0.19

667

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

136

3.27

11.77

1.4

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

265

1694

1.63

11.72

4.2

3.6

1.23

mmol/l

0.66

245

1468

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

212

2.78

11.62

2.2

1.5

—

(3017704) Immunofixation for Urine

103

3.63

11.61

1.3

1.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2311

21827

1.64

11.61

23.2

14.8

139.33

139.67

mmol/l

7.67

2274

21270

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

349

2.36

11.59

1.8

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

349

2.36

11.59

1.8

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.76

11.56

2.3

3.3

—

(3022313) Gas panel - Capillary blood

151

829

1.87

11.43

4.3

3.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

194

1150

1.74

11.39

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

123

632

1.99

11.32

1.4

311.28

294.70

ug/g

0.40

349

(3024354) Oxygen [Partial pressure] in Venous blood

227

1410

1.67

11.23

3.3

2.9

4.69

4.60

kpa

0.13

221

1366

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.75

11.18

1.3

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

172

991

1.79

11.14

10.6

9.6

23.92

24.41

mmol/l

1.43

167

966

(21494890) Protein electrophoresis panel - 24 hour Urine

195

2.81

11.08

1.3

2.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

218

2.70

11.04

1.6

—

(3019174) dRVVT (LA screen)

9.24

10.99

1.3

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

137

3.18

10.98

1.7

1.6

6.40

6.13

u/l

0.04

114

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

352

2.31

10.94

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2312

21890

1.61

10.87

23.3

15.0

3.93

3.95

mmol/l

1.89

2271

21290

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

176

2.88

10.76

1.2

41.37

38.75

mg/l

0.18

144

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

166

2.93

10.66

1.1

263.41

250.78

mg/l

0.17

141

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

339

2.31

10.52

1.2

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

111

565

2.01

10.51

4.1

3.5

0.41

0.37

u/ml

0.47

321

(3008152) Bicarbonate [Moles/volume] in Arterial blood

194

1178

1.70

10.45

7.2

25.12

24.47

mmol/l

1.46

183

1117

(4200892) Spirometry reversibility

232

1479

1.63

10.36

1.7

1.4

—

(3000330) Specific gravity of Urine by Test strip

178

1059

1.73

10.33

4.2

3.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

480

2.08

10.31

1.2

1.4

—

(3022145) Colonoscopy Study observation

345

2409

1.50

10.30

1.4

1.3

—

(3028433) Virus identified in Specimen by Culture

4.03

10.22

1.1

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

193

2.73

10.16

1.4

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

193

2.73

10.16

1.4

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

193

2.73

10.16

1.4

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

4.12

10.15

4.6

4.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

477

2.07

10.10

1.2

3.62

3.73

mmol/l

0.48

449

(3013166) Neutrophils/100 leukocytes in Synovial fluid

4.34

10.05

1.3

1.4

39.03

46.37

0.36

(3016650) Hepatitis A virus Ab [Presence] in Serum

347

2.26

9.98

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

446

2.10

9.95

1.6

1.9

4.41

5.09

mmol/24h

1.09

389

(3000492) Spirometry study

305

2093

1.52

9.88

1.8

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

180

2.76

9.78

1.2

1.0

—

(40768441) Liver Pathology biopsy report

164

2.84

9.70

1.4

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

127

3.10

9.64

1.1

1.28

1.07

u/l

0.49

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

479

2.04

9.63

1.4

1.5

171.70

1220.06

e6/l

1.07

388

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

355

2529

1.47

9.56

8.5

6.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.61

9.53

1.4

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

9.11

9.51

1.4

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

207

2.59

9.40

1.4

32.41

33.50

g/l

0.20

181

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

478

2.03

9.32

1.4

7.49

22.09

e6/l

1.19

364

(3042733) HLA Ab [Presence] in Serum

4.70

9.29

6.3

4.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

4.06

9.24

2.1

2.6

143.54

153.65

au/ml

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1169

10093

1.29

9.07

3.0

2.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

211

2.54

9.06

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

143

2.90

9.02

1.2

1.1

0.41

5.90

nmol/l

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

212

2.53

8.97

1.3

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

113

614

1.88

8.88

3.0

3.1

—

(3025941) Bacteria identified in Stool by Culture

201

1285

1.61

8.88

1.3

1.2

—

(40768446) Kidney Pathology biopsy report

3.80

8.78

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

174

2.67

8.72

1.3

95296.35

89630.97

e6/l

0.03

(3023199) Leukocytes [#/volume] in Pleural fluid

198

2.56

8.65

1.4

1.3

4221.48

2472.46

e6/l

0.49

138

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

316

2.22

8.65

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

231

2.41

8.42

1.1

—

(1761868) Lipid panel - Serum or Plasma

634

7751

0.76

8.18

2.9

2.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

128

743

1.76

8.14

1.8

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

545

4290

1.34

8.11

1.6

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

109

3.05

8.01

1.9

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

188

2.53

7.99

4.0

3.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

402

2.02

7.93

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

402

2.02

7.93

1.4

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

177

1129

1.61

7.91

8.2

7.2

24.96

24.90

mmol/l

0.08

177

1123

(3037121) Protein [Mass/volume] in Urine

121

697

1.77

7.91

2.4

3.2

0.49

0.27

g/l

0.98

263

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

126

2.88

7.91

1.8

1.4

—

(3012441) Differential panel - Pleural fluid

162

2.62

7.70

1.3

1.4

—

(21494434) Karyotype in Bone marrow

169

2.57

7.59

1.1

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

118

2.91

7.59

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

109

2.96

7.39

1.9

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

334

2.06

7.20

1.1

1.0

3.47

2.63

u/ml

0.32

151

(3044640) Blood type and Crossmatch panel - Blood

807

6794

1.28

7.17

2.8

2.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

181

1190

1.56

7.13

11.2

9.1

93.86

94.10

0.27

181

1184

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

151

2.61

7.12

1.8

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1563

14228

1.26

6.99

4.0

3.0

55.68

44.42

u/l

2.87

1471

13316

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

156

996

1.60

6.97

13.2

10.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

627

5134

1.29

6.90

2.8

2.2

—

(3045788) Cell count panel - Pleural fluid

161

2.51

6.76

1.4

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

223

1552

1.48

6.74

2.9

3.3

4.32

4.46

pmol/l

1.16

202

1370

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1573

14360

1.25

6.72

3.4

3.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

251

2.18

6.61

1.8

1.5

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

3.12

6.59

1.0

1.1

300.27

174.14

iu/ml

0.40

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

232

2.22

6.58

2.0

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

232

2.22

6.58

2.0

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

346

1.99

6.57

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

112

669

1.71

6.50

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

178

2.38

6.38

1.1

—

(1616796) Gas panel - Central venous blood

386

1.92

6.33

5.0

3.8

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

3.01

6.23

1.3

1.2

0.30

0.29

g/l

0.22

(40768806) Pleura Pathology biopsy report

174

2.38

6.22

1.4

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.74

6.14

1.0

2.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

169

2.39

6.13

1.1

1.5

13.15

11.83

umol/l

0.67

158

(3014765) Yersinia sp identified in Stool by Organism specific culture

111

673

1.68

6.11

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

112

681

1.67

6.10

1.2

—

(3024263) Appearance of Synovial fluid

2.85

6.10

1.1

1.6

—

(3047181) Lactate [Moles/volume] in Blood

102

607

1.71

6.02

6.3

7.2

1.38

1.27

mmol/l

0.57

529

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

274

2024

1.40

6.00

2.5

2.3

38.09

35.51

u/l

0.17

235

1725

(40767503) Oxygen content in Capillary blood by calculation

372

1.91

6.00

3.7

2.5

15.91

16.22

0.25

179

(3004119) Hemoglobin [Mass/volume] in Venous blood

170

1147

1.52

5.99

3.6

3.0

123.62

127.55

g/l

1.64

164

1120

(3045142) Bone marrow Pathology biopsy report

235

2.15

5.99

1.4

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

166

1116

1.52

5.95

2.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

118

2.65

5.90

1.4

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

118

2.65

5.90

1.4

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

149

2.44

5.79

1.5

1.3

—

(3003181) Sodium [Moles/volume] in Urine

363

1.90

5.76

1.4

1.3

60.21

61.88

mmol/l

0.13

295

(3009015) Lactate [Moles/volume] in Synovial fluid

6.87

5.73

1.5

1.4

4.21

6.07

mmol/l

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

207

2.20

5.70

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

115

721

1.62

5.59

5.0

3.7

24.86

24.95

mmol/l

0.14

104

668

(3044290) Cell count panel - Cerebral spinal fluid

434

1.80

5.51

1.4

—

(40761536) Microorganisms panel - Urine sediment

245

1805

1.40

5.46

6.8

4.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

3.24

5.45

1.5

1.2

36.11

38.27

g/l

—

(3000012) Reticulocyte production index

245

2.06

5.41

2.2

2.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

112

2.61

5.39

1.0

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

130

2.48

5.37

1.4

1.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

133

873

1.55

5.34

2.8

2.5

0.70

0.65

1.24

133

868

(3027273) Bicarbonate [Moles/volume] in Venous blood

133

873

1.55

5.34

3.7

3.1

25.61

25.42

mmol/l

0.22

128

849

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.41

5.30

1.2

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

11.28

5.29

1.1

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

135

1989

0.66

5.21

1.8

1.6

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

3.14

5.19

1.5

2.1

9.14

10.02

mg/l

0.22

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

287

1.94

5.03

1.0

1.1

—

(3024471) HLA-A [Type]

3.29

5.02

1.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

282

1.93

4.93

1.3

1.5

—

(21494755) Public health laboratory ask at order entry panel

146

2092

0.68

4.90

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.84

4.82

1.0

1.1

95.20

91.72

0.19

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

252

1.96

4.69

2.4

2.2

37.10

25.37

mg/l

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.17

4.65

1.2

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

340

1.81

4.59

1.1

1.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

132

896

1.50

4.58

2.9

2.5

1.21

1.20

0.10

132

889

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.73

4.51

1.3

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

114

753

1.54

4.50

6.0

1.78

1.59

0.90

106

705

(3016018) Differential panel - Cerebral spinal fluid

215

2.02

4.47

1.1

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.24

4.45

2.6

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

217

2.00

4.36

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1353

0.63

4.36

1.6

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.74

4.35

1.1

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

232

1.96

4.30

2.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

2.54

4.30

1.7

1.3

2.00

4.74

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.71

4.25

1.0

1.2

103.48

115.15

1.01

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

277

1.86

4.19

1.2

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

112

752

1.51

4.13

6.1

0.95

0.91

0.48

104

704

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

4.35

4.12

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.00

4.12

1.2

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

188

2.04

4.09

1.2

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

561

1.59

4.08

1.2

—

(3020891) Body temperature

112

754

1.51

4.08

4.6

4.3

—

(40761511) CBC panel - Blood by Automated count

2306

22384

1.32

4.07

20.9

12.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

281

1.83

4.02

1.2

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.77

4.02

2.3

2.6

—

(3009871) Measles virus Ab [Titer] in Serum

2.77

4.02

1.5

1.8

—

(3012516) Albumin [Mass/volume] in Urine

660

5731

1.20

4.00

3.5

3.2

774.62

352.76

mg/l

0.90

428

3491

(3051611) Lipemic interference index of Serum or Plasma

225

1.93

3.97

2.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.03

3.96

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

276

1.83

3.93

1.3

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

276

1.83

3.93

1.3

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

4.08

3.90

1.0

2.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.78

3.85

2.1

1.2

—

(3024932) HLA-DR beta [Type]

2.98

3.85

1.0

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

278

1.81

3.84

1.3

1.5

—

(3027315) Oxygen [Partial pressure] in Blood

421

1.66

3.84

5.9

4.0

7.84

8.58

kpa

3.07

416

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

101

2.39

3.81

1.3

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

101

2.39

3.81

1.3

1.6

—

(3030313) Adrenal Ab [Titer] in Serum

6.02

3.81

1.1

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.61

3.80

1.0

1.4

94.07

95.05

0.04

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

102

2.37

3.74

1.3

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

148

2.11

3.69

1.1

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

6.68

3.67

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

625

1.52

3.66

1.6

1.9

98.78

4.54

iu/l

0.49

224

(3019977) pH of Arterial blood

2.38

3.65

2.1

3.2

7.46

7.43

1.21

(3006922) Hepatitis E virus Ab [Presence] in Serum

142

2.13

3.65

1.1

—

(3023410) Appearance of Cerebral spinal fluid

211

1.91

3.63

1.4

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.41

3.62

1.2

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

596

1.53

3.58

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.36

3.57

1.3

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.36

3.57

1.1

1.9

—

(3009508) Creatinine [Moles/volume] in Urine

703

6196

1.19

3.55

3.5

3.1

6.81

7.11

mmol/l

1.06

600

5267

(3035880) pH of Pleural fluid

2.45

3.55

1.3

1.1

—

(3001729) Color of Synovial fluid

5.31

3.51

1.1

1.8

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

132

2.13

3.45

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2018

19372

1.20

3.45

5.8

5.4

38.47

39.30

mmol/mol

4.53

1909

17981

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

294

2381

1.27

3.43

1.5

1.7

1.45

1.42

0.29

259

2098

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

133

2.12

3.39

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

195

1.91

3.39

1.4

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.76

3.38

2.2

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

2.58

3.38

39.4

31.9

7.09

7.52

ug/l

0.33

(3012501) Base excess in Blood by calculation

421

1.61

3.36

5.8

4.0

2.57

2.60

mmol/l

0.03

289

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

137

999

1.39

3.33

1.5

—

(3013290) Carbon dioxide [Partial pressure] in Blood

422

1.60

3.33

5.8

4.0

5.09

5.08

kpa

0.04

417

(3020682) Albumin/Creatinine [Ratio] in Urine

682

6034

1.18

3.26

4.3

3.8

11.40

9.02

mg/mmol

0.52

444

3671

(3035933) Granulocytes/100 leukocytes in Blood

2.59

3.21

1.6

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.35

3.19

1.5

1.1

—

(3039000) Anion gap in Blood

420

1.59

3.16

7.7

8.8

10.36

11.21

mmol/l

1.23

377

(3018572) Chloride [Moles/volume] in Blood

421

1.58

3.13

7.7

8.8

104.51

104.99

mmol/l

0.27

378

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

121

875

1.40

3.11

1.7

1.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.69

3.05

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.44

3.04

1.1

1.0

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

2.90

3.02

1.4

1.1

21.34

25.72

0.20

(3006442) Creatine [Moles/volume] in Serum or Plasma

141

2.00

2.95

1.4

69.96

74.63

umol/l

0.56

141

(3014148) Varicella zoster virus Ab [Titer] in Serum

272

1.70

2.95

1.0

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

121

2.08

2.92

1.0

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

159

1220

1.32

2.84

1.5

1.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

4.46

2.79

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.17

2.77

1.0

1.1

1417.22

1628.79

miu/ml

0.43

(3009542) Hematocrit [Volume Fraction] of Blood

2419

23778

1.35

2.76

37.8

19.7

39.55

39.77

1.25

2294

22394

(3050794) Legionella sp Ab [Presence] in Serum

5.01

2.73

1.1

—

(3007461) Platelets [#/volume] in Blood

2420

23797

1.34

2.68

37.7

19.7

259.36

259.20

e9/l

0.04

2391

23240

(3028679) Herpes simplex virus Ab [Presence] in Serum

126

1.99

2.65

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.80

2.64

1.0

1.2

94.67

74.75

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.15

2.64

1.3

1.2

478.53

130.79

ug/l

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.66

2.62

1.1

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.47

2.62

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.26

2.60

2.9

2.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.34

2.60

1.0

1.2

—

(3024731) MCV [Entitic volume]

2420

23807

1.34

2.58

37.4

19.6

91.49

90.90

7.81

2405

23498

(3010813) Leukocytes [#/volume] in Blood

2420

23808

1.34

2.57

37.7

19.7

6.45

6.66

e9/l

3.78

2383

23182

(3035941) MCH [Entitic mass]

2420

23809

1.33

2.56

37.4

19.6

30.23

30.20

0.31

2404

23498

(3026361) Erythrocytes [#/volume] in Blood

2420

23811

1.33

2.54

37.6

19.7

4.37

4.45

e12/l

13.73

2384

23190

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.74

2.54

1.0

1.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.74

2.54

1.0

1.2

75.60

69.00

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

5.46

2.54

1.0

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2129

20673

1.18

2.53

4.6

4.4

5.67

5.85

mmol/l

9.00

1988

18962

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1088

0.70

2.51

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.17

2.51

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.17

2.51

1.2

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

421

1.51

2.50

3.5

2.7

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.11

2.48

1.4

2.2

16.10

103.29

ug/l

0.53

(4212803) Bone marrow aspirate examination

4.38

2.47

1.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

2420

23819

1.33

2.47

37.9

19.8

131.16

133.67

g/l

17.30

2405

23505

(3025018) Bordetella pertussis Ab [Titer] in Serum

144

1.88

2.46

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.82

2.46

1.1

1.3

—

(40765096) Chromosome analysis panel by Banding

2.46

2.45

1.3

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.14

2.44

3.1

2.5

—

(40757373) Influenza virus identified in Isolate

2.90

2.41

2.2

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.90

2.41

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

3.34

2.39

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

146

1.86

2.37

2.0

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

370

1.53

2.36

2.8

3.1

0.76

0.82

nmol/l

0.53

286

(3022689) Creatine [Moles/volume] in Urine

2.38

2.29

2.6

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.95

2.28

1.9

1.6

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.62

2.27

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.11

2.22

1.1

1.3

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

5.56

2.21

1.0

1.8

393.40

164.44

ug/g

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.69

2.20

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

4.29

2.15

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.01

2.14

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.30

2.14

1.1

—

(3024928) Oxygen saturation in Venous blood

407

1.46

2.06

2.7

2.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

110

1.92

2.05

1.1

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

162

1.74

2.02

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.08

2.01

1.0

1.2

—

(3004451) EKG impression Narrative

2.03

1.95

1.4

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

371

1.47

1.94

1.3

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

4.55

1.94

1.0

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

180

1.67

1.92

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

113

1.87

1.91

1.1

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

526

4742

1.14

1.88

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

407

1.43

1.88

1.5

1.4

15.96

28.98

u/l

3.41

337

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.65

1.86

1.1

1.2

75.22

82.86

ng/l

—

(3006462) Nitrate [Presence] in Urine

100

1.91

1.85

5.3

3.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

152

1.72

1.83

2.2

2.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

4.17

1.82

1.0

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

238

1.56

1.81

1.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

295

2558

1.17

1.80

4.3

35.36

32.79

3.55

231

1753

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.01

1.80

1.1

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.76

1.79

1.3

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.35

1.77

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

243

2079

1.19

1.75

4.0

3.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

162

1.67

1.74

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

524

1.37

1.74

1.3

11.92

12.67

u/l

0.17

422

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

623

0.68

1.70

1.5

—

(3014271) Vancomycin [Susceptibility]

1.92

1.70

3.8

2.9

—

(3003338) MCHC [Mass/volume]

1890

18346

1.12

1.69

32.2

17.0

329.96

331.63

g/l

12.94

1881

18216

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.16

1.66

1.0

2.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.59

1.66

1.3

1.2

—

(3006270) Folate [Moles/volume] in Blood

174

1.62

1.61

1.2

1.1

356.60

396.15

nmol/l

0.48

161

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.91

1.59

1.6

2.8

58.33

165.60

umol/l

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

159

1.64

1.59

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.21

1.57

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.11

1.55

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.11

1.55

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.60

1.51

3.0

2.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.60

1.51

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

299

1.45

1.51

1.3

1.2

56.67

28.28

u/l

0.34

254

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.16

1.50

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

158

1320

1.21

1.50

1.4

1.3

31.10

30.56

iu/l

0.07

139

1139

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.37

1.45

6.0

8.3

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.50

1.45

1.0

3.1

—

(3008295) Osmolality of Serum or Plasma

228

1.50

1.44

1.7

1.4

275.59

278.67

mosm/kgh2o

0.35

172

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

578

0.70

1.43

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

577

0.71

1.42

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

576

0.71

1.41

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

575

0.71

1.40

1.4

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.18

1.40

1.5

1.2

0.78

4.90

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

469

0.68

1.39

1.5

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

2.00

1.38

1.4

1.2

110.23

137.91

pmol/l

0.57

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.94

1.36

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

215

1.49

1.35

1.5

1.2

—

(3005033) Fetal Nuchal fold Thickness US

466

0.68

1.35

1.5

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

235

0.55

1.35

1.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

393

1.36

1.33

1.1

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.97

1.32

1.7

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

801

1.25

1.31

2.1

2.0

11.17

11.34

nmol/l

0.07

715

(3047189) Immunofixation for 24 hour Urine

1.74

1.31

1.3

1.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

403

1.35

1.30

1.5

1.4

0.32

0.37

nmol/l

0.45

309

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.50

1.30

3.7

2.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

749

1.25

1.28

1.6

1.3

194.68

222.78

miu/ml

0.29

369

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.78

1.28

2.6

2.4

—

(4281824) Cell count and differential, peritoneal fluid

293

0.61

1.28

1.3

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

401

0.67

1.27

1.3

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.79

1.27

1.4

1.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

107

1.69

1.25

1.2

1.4

—

76.00

—

(3011985) Renin [Units/volume] in Plasma

295

1.40

1.24

1.6

1.4

47.68

40.64

mu/l

0.22

270

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2062

20212

1.11

1.23

4.1

3.8

1.24

1.27

mmol/l

1.63

1935

18625

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

2.04

1.22

1.5

1.4

27.80

28.59

—

(3002256) Pathology report gross observation

310

2785

1.13

1.21

1.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

164

1.53

1.20

1.6

1.9

15.76

19.45

nmol/l

2.23

153

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

182

1.49

1.15

1.3

1.2

0.21

0.75

u/ml

1.12

(1761482) Bacteria [#/volume] in Urine by Culture

500

1.29

1.15

5.7

4.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.50

1.15

1.0

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

484

0.72

1.14

1.5

—

(44813793) Dust mix specific IgE antibody measurement

167

1.50

1.12

1.2

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

184

1.47

1.10

5.6

2.7

165.35

23.96

mg/l

0.81

131

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.78

1.10

1.5

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2146

21116

1.10

1.06

4.5

4.3

4.60

4.78

mmol/l

14.56

2033

19695

(3017569) Oxygen content in Arterial blood

1.67

1.04

4.3

2.6

—

(3006653) Thiamine [Moles/volume] in Blood

114

1.58

1.02

1.1

1.4

135.39

131.89

nmol/l

0.11

114

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

239

1.39

1.00

2.7

4.4

19.24

90.64

u/ml

1.60

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.00

1.00

1.9

1.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.00

1.00

4.1

8.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.62

1.00

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

107

1.59

0.99

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

629

1.23

0.99

2.1

2.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

538

0.76

0.98

1.4

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

469

0.74

0.97

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.80

0.96

2.0

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.74

0.96

1.0

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

235

2111

1.12

0.95

1.5

1.6

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

133

1.51

0.94

1.3

1.5

19.55

24.60

umol/l

0.36

125

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

666

0.79

0.92

1.6

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

269

1.34

0.92

1.6

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2130

20983

1.09

0.92

4.5

4.2

1.53

mmol/l

0.21

2008

19463

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.82

0.92

1.9

2.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.82

0.92

1.9

2.9

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.15

0.91

1.2

3.3

—

(3051593) INR in Capillary blood by Coagulation assay

1.67

0.91

11.7

10.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

449

1.25

0.87

2.0

2.4

173.58

102.51

ug/min

0.20

272

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.86

0.87

1.6

2.2

20.05

18.83

umol/l

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

136

1.47

0.86

1.0

1.4

—

689.17

—

(3048879) Bone marrow aspiration report

1.76

0.83

1.1

2.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

146

1.44

0.82

1.3

1.7

—

(40757494) Bilirubin.total [Moles/volume] in Blood

105

1.53

0.81

1.4

2.4

—

39.33

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.55

0.81

4.1

2.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

392

1.25

0.80

1.1

3.67

4.15

u/ml

0.09

183

(3000285) Sodium [Moles/volume] in Blood

1.82

0.79

1.8

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.77

0.76

2.3

—

(3020650) Glucose [Presence] in Urine

1.64

0.73

1.1

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

219

1.33

0.73

4.2

2.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

228

2491

0.91

0.72

1.8

1.7

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.80

0.72

1.1

1.2

—

4.30

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

107

934

1.15

0.72

2.0

4005.36

4483.06

u/l

0.05

379

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

194

1.34

0.71

2.5

—

(3015183) Erythrocyte sedimentation rate

134

1.42

0.71

1.1

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.85

0.68

1.2

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.67

0.68

1.7

3.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

121

0.58

0.67

16.6

12.3

699.57

873.89

nmol/l

—

116

(3001019) Free T4 and TSH panel - Serum or Plasma

124

1394

0.88

0.67

1.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.79

0.66

1.2

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.59

0.65

1.0

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

236

0.72

0.64

1.1

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

891

0.86

0.63

1.5

1.8

7.23

4.19

mg/l

0.53

651

(3050129) First trimester maternal screen panel - Serum or Plasma

718

0.85

0.62

1.5

1.4

—

(3033799) Differential panel - Peritoneal fluid

1.59

0.61

2.4

1.9

—

(3028707) Methadone [Presence] in Urine by Screen method

344

0.78

0.59

1.2

2.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.53

0.59

1.8

1.1

—

12.00

—

(3011648) Oxygen content in Venous blood

157

1.34

0.59

2.1

2.2

11.11

10.82

0.14

157

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.67

0.56

1.3

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

322

3030

1.07

0.55

4.2

4.8

1.70

2.54

ug/l

3.72

281

2683

(3032057) Clostridioides difficile [Presence] in Stool

1.54

0.53

1.7

1.9

—

(3027008) Opiates [Presence] in Urine

747

0.87

0.52

1.3

1.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

138

1258

1.10

0.51

1.1

1.0

—

(3002619) Bacteria identified in Specimen by Culture

1.46

0.50

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

379

0.82

0.50

1.6

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

744

0.87

0.50

1.3

1.9

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

380

1.19

0.50

1.1

0.21

1.28

u/ml

2.07

151

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

728

1.13

0.48

3.0

3.5

21.97

2169.76

u/ml

0.93

628

(3002079) Sodium [Moles/time] in 24 hour Urine

102

1.37

0.47

1.2

1.3

121.57

155.04

mmol/24h

1.11

102

(1002224) Polysomnography panel

882

1.12

0.47

1.1

—

(3028300) Cannabinoids [Presence] in Urine

750

0.88

0.47

1.3

1.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

580

0.86

0.47

1.3

1.9

—

(3027944) Amphetamines [Presence] in Urine

737

0.88

0.45

1.3

1.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

442

1.16

0.43

1.1

2.23

2.25

u/ml

0.01

218

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.61

0.43

1.0

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

812

1.11

0.42

1.8

1.6

289.13

308.68

mu/l

0.30

727

(3051651) Icteric interference index of Serum or Plasma

131

1.30

0.42

3.6

3.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

140

1.29

0.42

1.2

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

294

0.81

0.41

1.2

1.4

3.10

3.86

ug/l

0.29

258

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.38

0.41

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

169

1574

1.08

0.41

1.8

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

15.40

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

141

1.28

0.40

1.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.37

0.40

1.2

1.5

—

808258.33

iu/ml

—

(3016879) Cocaine [Presence] in Urine

687

0.89

0.40

1.3

1.9

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2163

21467

1.05

0.39

4.9

4.7

2.67

2.83

mmol/l

14.69

2045

19903

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

148

0.74

0.38

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

162

1518

1.07

0.35

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

165

1757

0.93

0.35

2.7

3.0

0.69

0.75

ug/l

0.32

108

1145

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

223

2115

1.06

0.34

3.0

4.1

3.11

21.22

ug/l

3.46

174

1693

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

255

1.18

0.34

2.7

3.2

3.99

26.05

nmol/l

0.51

247

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

132

1232

1.08

0.33

1.6

1.7

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.31

0.33

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.31

0.33

4.5

3.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

528

0.89

0.31

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

352

1.14

0.31

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

316

1.14

0.29

2.1

1.7

48.89

42.64

nmol/l

0.43

302

(3034274) Bile acid [Moles/volume] in Serum --fasting

288

1.15

0.29

2.6

2.0

5.77

6.09

umol/l

0.09

200

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

110

0.73

0.28

1.0

2.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

167

1.20

0.28

1.8

2.3

1.18

2.32

u/field

0.87

(3051387) C reactive protein [Mass/volume] in Capillary blood

450

1.11

0.28

4.4

3.7

28.28

24.34

mg/l

0.37

287

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

132

1.21

0.25

1.4

1.3

—

(40768793) Breast Pathology biopsy report

661

0.92

0.23

1.2

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

1.32

0.23

1.2

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

419

1.10

0.22

2.0

2.3

0.84

0.85

nmol/l

0.02

349

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.22

0.22

1.0

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

107

1.22

0.21

1.8

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

0.50

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

182

1.16

0.21

1.8

1.7

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

1.04

—

(3011288) Drugs identified in Urine by Screen method

502

0.91

0.21

1.6

2.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

584

5725

1.03

0.21

1.6

1.7

1.36

1.37

mmol/l

0.12

514

4842

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.20

0.0

1.0

—

21.70

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.25

0.20

1.0

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

232

2247

1.04

0.18

1.5

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.13

0.18

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

107

1018

1.05

0.18

1.4

—

(3044007) Cell count panel - Peritoneal fluid

1.17

0.17

1.4

2.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

300

1.10

0.17

1.4

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

349

1.09

0.17

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.73

0.17

1.4

1.6

—

(4146454) Self-monitoring of blood glucose

216

1.11

0.15

3.0

2.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.10

0.15

3.4

1.5

103.69

84.70

nmol/24h

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

221

2270

0.97

0.14

1.7

2.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

118

0.85

0.14

1.2

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

287

1.08

0.12

1.5

1.3

—

nmol/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

259

1.08

0.11

1.3

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

348

1.06

0.10

1.1

109.86

1690.46

iu/ml

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

261

1.07

0.10

1.1

0.06

0.31

u/ml

1.11

(3010726) Horse dander IgE Ab [Units/volume] in Serum

361

1.05

0.08

1.1

0.31

1.79

u/ml

3.64

173

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

736

1.03

0.08

1.8

1.9

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

108

1.11

0.07

1.7

1.3

—

(3025130) Human papilloma virus identified in Specimen

396

0.96

0.06

2.4

1.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

286

1.05

0.06

1.1

2.77

4.69

u/ml

0.57

105

(4034850) Laboratory test

708

0.97

0.05

18.6

9.1

—

(3003694) ABO and Rh group [Type] in Blood

599

5954

1.01

0.05

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

241

2433

0.99

0.04

3.6

4.2

22.73

21.16

0.86

105

1136

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

352

0.97

0.04

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

252

2541

0.99

0.04

1.8

2.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

137

0.95

0.01

1.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

547

0.99

0.01

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

115

1.04

0.00

1.9

1.4

1.54

1.22

nmol/l

0.44

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

149

1.01

0.00

4.0

6.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

169

1.01

0.00

1.9

1.5

0.87

0.96

g/l

0.58

169

(40768800) Prostate Pathology biopsy report

181

0.99

0.00

1.1

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

144

0.97

0.00

1.6

1.3

1.57

1.62

g/l

0.30

144

(3020491) Glucose [Moles/volume] in Blood

164

0.98

0.00

1.6

6.49

6.56

mmol/l

—

111

(3014133) Dog dander IgE Ab [Units/volume] in Serum

312

0.99

0.00

1.1

4.35

3.00

u/ml

0.13

136

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.2

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.3

—

171.00

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.0

—

72.20

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

-0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

1.9

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.6

—

1901.32

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

-0.00

0.0

1.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

300

1.00

-0.00

3.6

5.3

379.26

366.04

umol/l

0.20

259

(37021550) Renin [Units/volume] in Plasma --upright

0.98

-0.00

1.0

1.3

50.58

63.07

mu/l

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.00

-0.00

1.6

1.3

0.91

100.81

mg/l

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_MCTD and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_MCTD	1.667 [1.52, 1.83]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.294

During the follow-up period (1.1.1998 — 31.12.2019), 1763 out of 9083 females with M13_MCTD died.

Males

Parameter	HR [95% CI]	p-value
M13_MCTD	1.845 [1.6, 2.12]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 789 out of 2361 males with M13_MCTD died.

Mortality risk

Mortality risk for people of age

years, who have M13_MCTD.

N-year risk	Females	Males
1	0.185%	0.328%
5	0.883%	2.007%
10	2.493%	5.008%
15	4.925%	9.315%
20	8.356%	15.147%

Relationships between endpoints

↥

Index endpoint: M13_MCTD – Mixed connective tissue disease

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Mixed connective tissue disease

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints